NPOTOKOJI N9 2

Tlsac 16 nq 2|r1 6 TroTtT/r{A - p, 1O ?n u:.^ p KOTT-Erznr:n// I..OOTI D v-d.,",,^--+lncu/ ru. UJ.LUlv LvA,LLlst D -_,Ar lJ KduylHeTa HaVnpaaurerR Ha ,,KOI{-Byplac" EOO,[/ Ha a.qpec: rp. Byprac , 6yn. "CteQaHClau6o.rioB" Ns 73, KoMrACr fr. B c.bcraB:

flpegcegarer : ,[apmHa Cro.qHoea - rrJ]aBHa Me.qr4urrHcKa cecrpa, ,,KOU-Eyplac/'EOO,U;

9.nenone:1 . .[eaua llerpoea - npaBocnoco6eH rop]4crr flo rJr. 14 / ar. 5 or 3On, .qerzcrBarlK.bM Iarara Ha orKpmBaHe Ha rrpoue.qypara - 14.03.2016 t.;2. MizHro Koee - cr.eKclepr, lnpercgvta *3IIC,UT3C" - O6uusa Byplac, no ul .14,ar.5 or 3O[;3. flmaHa As4xraeea - HaqaJrHr4r( or.qeJr I P3lA Eyplac I no ufi.ILt a"rr.5 ol 3OIli4. lApuua To4opona - u.Q. ylpaBr4Ter 6orHZqHa arreKa/ Ha ,,KOU-Eypr,ac"EOO[,

B I43nbJIHeHI4e Ha 3anoBel Ns 103 or 04.05 .2016 ro.qr4Ha Ha Vnpaemlens Ha"KOII-Eypr,ac" EOO,q, ce cr6paL .qa npo.qbJrxrz cBo.rrra pa6ora flo pa3rurex.uaHe Han--mqnr/frTlma nd-QepTj4 3a yqElcTr4e orKpuTaTa npoue.uypa, 3a B'bsrrarlaHe HaA6'ra-mEAut n^n'bqKa/ c npe.qMer: ",UocraBKa npo.uyKT]4 no..-p'bqKa/ C npe.qMef : ",IOCTaBKa nq rrs^oyulDsnprJloxeHa cneqzQvrKarJvrfr.'t .

flporlegypara e orKpr4Ta c Peueuue Ns 09 / 14 .03 .2016 11 . , perrr4crpilHaHa e AOllnon Ns 00232-2016-0003, ny6"nmrcyeauo o6.cBreHr4e B Pon Ne 1L9 3tB/14.03.2076rr. m n OB ua EC Ns 2016/3 055-091550 /I8.03.2076 t.

flpe4cegareJLqr Ha KoMr4ctAfl.Ta npoBepr4 cbcraBa Ha npr4cbcrBarrlr4Te.f-Na 7lpmua Togopona non'bJrHr4 .qeKrapaur4.rr, c'bfracHo .r.r.35, dJr.3 or 3arcoua 3ao6uecreerture nop.bqKyr, cJIeI 3arIoBHaBaHe c,bc cnI4cBKa Ha yrracrHl4rl,l4['e I rrolalrwoQepru, nopa,El4 orc'bcrBr4ero cI4 o[' rrbpBoro 3aceEaHJ4e Ha KoMJ4c]4.sra.Tlnancon:manqm

^mrnrtr ee-an:HTtram^

H: \Iu A amqrtrrrrla nn n: nTl nrhar'Y/-pTI4 3a yrlacTI4e B npoue.qypaTa ' 6e l43npaTeHnnnf, ?An ilIo 1L I c KoHcTaTaI_lI4UTe Ha KONlvrCVrs.T a OTHOCHO npelcTaBeHUr re,4OKyMeHrr4 B rrr4KoBe Ns 1 ,,.{OrCyVeHrU 3a nO,46Op", T.qXHara pe.qOBHOCT tA

cboTBeTCTBI4eTO rt}{ C I43%CKBa:H-rAfl|Ia Ha B.rg.[ONZrer.q. Ha OCHOBaHT4e il B CpOKaco 9 ou 3oll BceKrt yrlac['H]4K Moxeue .ua npe.ucraBr4 JTr4ncBaur4rMJl .UUI qJL.

.qoKyMeHTI4 !7J7Vt IOKyMeHTW, C KOT4TO ,44 OTCTpaHI4 KOHCTaTtlpaHI4 HeCbOTBeTCTBVTAc Kpr4Tepuvrre 3a [o.u6op Ha BrsroNr,rren.q.

B 3aKoHoBl4.s cpoK ca nocvbnuJrvr ,UonbJIHrreJrHr ,EoKyMeHrr4 or yqacrHrrr-lr4Te,,TbP|OBCKA JII4IA - HAII" AI u ,,OAPKOJI" AI.

l,carnrarrone n:anJIeX.qa .qOII5IIHI4TSJIHO ;1peICTaBeH14Te .qOKyMeHTtI , nO pe,Ia HareJ+

flocrbnBaHero trM npr4 B'b3Jroxr4Ter.q.

1. ,,aDAPKOJI/ A,qC flr{cMo BX. Ne I33 /71 . 05.2016 rr. r,r B saKoHHil.q cpoK, yqacTHr4Kbr npe.qcraB.qCJIC.qHYITC EONBTHI4TCJ]HII .UOKYMEHTI4 :

- Cnrc'lr< Ha.qoKyMeHrr'r4le/ cb,4bpxarqvi ce B oQeprara ga OII Ne B;- Konr4e Ha Jfi4rIeHrJrAA 3a .4erZHOCTr4 C HapKOrrns.HW BeUIeCTBa.Kotrtvtcws,ta cr{r4rla, rJe yr{acrHI4Kbr e flpe.qcraBInJr BCvr\4Kvr trSvrcKBatql4 ce IoKyMeHTvrq^ nnT{^qRAHF /rborBercrBt4ero cIA c Kplzreplrvre 3a no46op Ha B'g="[oNnre.[.q noo|I Ns B.Kovlcwnna .uonycKa o0eprara Ha yrJacrHI4Ka .qo yqacrl4e B npolleEypara riooQepr4paHr4Te o6oco6eHr4 rto3vrrJurr .

2. //TtProBcKA JIHIA - IIAII'/ A'qC nrzclao ex.Np 136/12.05.20 16 r'. u B 3aKoHHr4.c cpoK, yqacrHt4K.bll e npe.qcraBr4JlKonl4e Ha y.qocroBepeHI4e or MEAJI-TrploBr4rrIe A[ Karo ,EoKasa['eJrcrBo BaI43B'bpUeHaTa KbM Herlo l4 .qeKJIapr4paHa oT yr{acTHI4Ka .qoc['aBKa.Kot'wtcuata cqvlTa/ .ae yqacrHl4Kbr e npe.ucraBrrlr BcvluKra rr3r/rcKBarrlr4 ce roKyMeHTr43d AUKdslrdHe cborBerl'crBilero cra c Kpl4Teptrvrre 3a nogoop Ha Bsg.[oxmrer.q roo@eplrpaHr4Te or Herro o6oco6eHw no3vrrJvrfi.Kottvtcvts:ta .qolycKa oQeprara Ha yr]acrHr4Ka .qo yqacrr4e B fipoue.qypara nooQepzpaunle o6oco6enm no3tArJrAu .

KoNiracvr.cra npl4crbnBa KbM pa3rlJrex.qaHe Ha npe.qJroxeHrrHrya 3a r3rbJrHeHyre HanopbqKa['a nJI]4KoBe Ne 2 ot o@eptmre Ha yqacrr4uJ4['e, ro o6oco6enmleno3ul\nv I no KouTo Ir4 e .uonycHaJra .uo yqacTr4e B [poue.EypaTa .

Pagl"neN.qa ce c'borBercrBl4ero vrv' c nocrraBeHvrre vr3vrcKBaHI4.rI na Btg.noxI4TeJIg 3ar4gn'bJrHeHrte Ha rop.bqKaraf no pe.qa Ha nocr.bfiBaHero ua oSeprrre.

1. /,coeAPlIA TPEI\IUHT" A,qVq: r-rngtzx+-.n ortronrzn: T/anqnHAHrra nnon^/am^ Ha flopbqKaTa Ha cJre.EHr4TenAk2namRAHT/ nn^nrrt.-'. / TTT-I\..I-JAyKTr4 (Jlrr) , nO KOI4TO e .qOnyCHaT .4O yqaCTI4e:

onNe

N9Eon ATC NN

tleKapcrEeHaQopMa

HA ATUBHOTO

ne(apcTBeHo BeqecTBo

nporno3hh(onuqecTE

a

6poi B

npeffaraHora

ona(oB(a

nplrexaren Hapa3peuednero 3a

ynorpe6a

Cpor HaroaHocror nPY -

B

rOAhH'5

1 . Anrrrporu6oru.{t-t H neKapcrBa 5 900

1 1 BOlABO5 Enoxaparin sodiumsol. inj,, pre-

filled syr.4000

lUi0,4ml 500 KIIEKCAH arr,tn.

40rar/0.4trrn10 Sanofi - Aventis

1 z BO,IAB06 Nadroparinsolution for

iniection 3800 tu 1 600OPAKChNAPhHaun.urno. 0.4un 10 Aspen Fharma 3

BOlAB06 Nadroparin solution foriniection 5700 tu 200 OPAKChNAPhH

avn.unp. 0.6vn 10 Aspen Fharma

1 BO1AB1 2 Bemiparin sodium solution forinjection

3500 u 1003t460P aun.3,500lU/0.2run

zMenariniInternationalOperations

2

3, Anru6axrepuanHH reKapcrBa 2 360

J01M02 Doxycycline caps. 100m9 600 AOKC14r_lilKIr14Hranc. 100rur

o Arraanc EA,[ 4

2 J01 CR02Amoxicillin/ Clavulanicacid

tabl. film -coated

6/5mgl125

mo500

MElOKNAB875rur/125trrr

14MedochemieLtd.

z

o JO1 GBO3 Gentamicin solution forinjection

40mg/m -

2ml350

TEHTAM14U14Harun. 8Onar/2urn

10 COOAPMAAA 4

7 JOlG806 Amikacin solution forinjection

500mg/2 m

-2ml250 AMt4KALll4H aun.

25Ourlun 2r'tn 10 COOAPMAAA z

9 JO1 MA1 2 Levofloxacintrlm-coated

tablets500m9 80 IIEBOKCA $nnu

T2nn 5t tt IMr Arraenc EA.Q

? 10 JOlXAO2 Teicoplaninpowd.andsolv. for

sol.for ini.400 mg 50

TAPI-OUhE aun.400Mr + pagre. 3irn 1

CanoSuAeeHrilc

4. flerapcrea 3a neqeHre Ha cbpAeqHo-cbAoBh3a6onFBaHhg

4 1 c01M05 Digoxin sol. Inj./inf.0.5

mol2ml 150 [t4FOKCklH arrltn.

0.25ntr/un 2ntn10 COOAPMAAA

4c01 BB01 /NO1 BB02

Lidocaine solution forinjection

20mg/ml-10m1

1 000Ilh,4Ol(AhH aun.200ur/10run

50 COOAPMAAA 2

4 c01BD0'1 Amiodaronesolulto lor

intravenousinfrrsion

50mg/m -

3mllzv KOPAAPOH arun.

150ur/3unCanogu-AeeHrHc

z

4 c01 cA04 DopamineHydrochloride

concentratefor solutionfor infusion

40mg/ml -

5ml100 lOflAMlzlH aun.

4o/o 5vin10

WarsawPharmaceutical

5 c01cA24 Epinephrine solution for 1mg/ml- 1ml

100AlPEHAIIkIH aun.1nril un 10 COOAPMAM 2

6 CO1 DAO2 Glyceryl trinitrate solution forinfusion

1 mg/ml- 50ml

OUNEPIITHTAHHT6n. 50ur/50un 1

ucnwarzPharma AG,

5

7 c02Ac01 Clonidine solution forinjection

0,15m9 800XJtUAASUJil/tHaun.0.1Srritr/un'1 run

10 COOAPMAAA

4 8 c03cA01 Furosemide solution forinjection

10mg/ml -

2ml1 200 OYPO3EMh,Q aun.

20t'trl2uin'10 COOAPMA AA

4 10 c03cA04 Torasemide solution forinjection

20mgl4ml

300TPhQAC aun.20url4uin 5

MenannlInternationalOoerations

4

A 11 c03cA04 Torasemidesolution for

injection10mgl2

ml1 000

TPk'IOAC aun.1lurl2un

MenariniInternationalOperations

4

5. flporreoeb3nanHrenHH h o6es6onsBaulr neKapcrBa 8 500

5 AO3ADO2 Drotaverine solution foriniection 40mg 2 500 IPO Cf1A3 arun.

20ur.lun 2un 10 fuu$au A[6. flporreoeb3nanhrenHh neKapcrBa 2750

6 ,l MOlAE03 Ketoprofen solution forinjection

100m9 200 flPOAEHh! Qn.1 00Mr + pa3rB.

oCanoQuAaenruc,ErnrapuR

o a MO1AE17 Dexketoprofen solution forinjection

50mg 2 500AEKCKETOnPOOEH 50ur/2un urrxo-o

S.C.RompharmCompanyS,R.L.

4

6 3 MOlAHO4 Parecoxibpowd. and

solv.forsol ini

40mg CU,$4HACTAT cyxaaun. 40ur + pa3TB.

2un1

Pfizer LimitedUnited

7. AnruxeruoparhgHH H aHThaHeMhqHh neKapcrBa 380

7,l

BO2BAOl Phytomenadione solution foriniection 1omg 160 aun. 1Orur 1un

Pou SrnrapnnEOOJl

7 2 B03AC02 Saccharated lron Oxidsolution for

iniection 100m9 120h,QAQEP aun.100trrr 5rrltn

QapManofEOOn

vr{acTHI4K'bT npe,uJlarra cpoKoBe 3a l43r'bJrHeHr4e Ha nopbqKaTa: npr4 nepr4oIr4qHr4n^amaRkT/ nn '7 |Avvrsu:\,! Av , \ceEeMJ paooTHI4 AHVr OT nO,UaBaHe Ha 3a.rrBKaTa, npll BB3HI4KHaJIaHeo6xo.UI4Mocr tI3BbH cpoKa Ha nepr4o.qr4qHrrre .qocraBKz .qo 3(lplz) pa6orHr4 EHvr.Ilna nnnvourramn

^lryvAulvJtlv ,.4y e BaJII4.qHo ,4o 04 .08.20 16 r'.

He Qrlyprpar n lIo=vttfieuwfl. JreKapcrBeH cnrrc,bK (llJIC) -llpvn.2, aKTyaJreH K.bM

.Earara 20 ,04.2016 fr. , nocoqeHa e o6.qeneHr4e['o 3a nop'br{Ka['a, c npe.qJroxeH]4TeTbproBcKI4 HaI4MeHoBaHil.q rA npilTexareJrr4 Ha Pa:peueHyrero 3a ynorpe6a (llPV) , aBrg"noNmren.qt e Barr4car Karo 143r4cKBaHe B .uoKyMeHT arJus.Ta ro rrpoqelypara :

-.Tlnc nnoxct-ltr.nc rroTaer-r-TFRoIJT/ nnarTVKT'I4 na iblzf Trvnrzn:.r, n Iloa.vrnvteuvt q TTeTc^n-TFRAH,tLLt'eAsLvJL\ rryvA/ r\ryr As \ytLL J trtltr4t u

cnr4ctK(|IJIC) - llpmloNeHr4e 2.".Ha ocnoBaar4e Doper4BJroxenoqso u rro pegaKorrrvtcylrrrEa rrpenJrara oiDepratra Ha ylractrHgrKaqpoqegyPatra rlo cJreAHr4Ee IroMeIrKJraEl|[)% otr,3. 9. ; 4.6. ; 5.3.

rra sJr. 69 t alr.L t r . 3 otr SOII ,,qa 6rge oEctrpaHeHa otr yrilactrue B

o6oco6enzre LtoBwrJWr: NgN 3.2. ;

flo ocranaJrrrtre rrolaeHKJraEypr4 otr o6oco6erurre r:og:,rrJryt I Korrrrael,zrula cql%tra, E€o(Deprnara rra lrqactlnrrKa orloBaprr rra vgrrcKBan%rrra rra BBBroxclrr'eJrs w Eo[ycKacEr4atra ,qo or{eltrrBal{e 14 KnacrrpaHe lro trtlx.

Kouucrsra KoHctrarrdpa/ qe npe.uroxeHrrre or yqacrHr4Ka JIll:

J01 CR02Amoxicillin/ Clavulanicacid

tabl. film -coated

875mgl125

mo500

MEAOT(JTAB875ur/125tvtr 14

MedochemieLtd.

9 JO1MA,l2 Levofloxacin film-coatedtablets

500m9 80IIEBOKCA $unura6n 500ur

7 Arraerc EAA

4 6 c01 DA02 Glyceryl trinitrate solution forinfusion

1 mg/ml- 50ml

60NEPNhHTAHhT6n.50ur/50tritn 1

SchwarzPharma AG.

5 3 AO3ADO2 Drotaverine solution foriniection 40mg 2 500 llt,u ut tAiJ aMn,

20ur./un 2un 10 A,quSaM A.q

2. //TBPTOBCK;A JII4TA - HAIIN A,qVqar-.ngrzrc.r-.n rt/honrrn: r/anLnuauv aqurrrvrr\Dr vWey,rys "'-"-""-"V-e npe.[MeTa Ha |IOp'bqKaTa Ha CJIe.EHI4Te OIInak:n-mpaur/ nno.uyKTTI/ IIO KOI4TO e .qO[yCHaT .qO yqaCTI4e:

VqacrFII4rcgr npe.qJlara cpoKoBe 3a 143nbJIHeHr4e Ha rop.brrKara: npn rrepuo4rlr4.Hu.EOCTaBKI4 .qo 9(.Uener) pa6oruu EHyI OT no.qaBaHe Ha 3a.qBKaTa, nPV B'b3HilKHaIIaHeo6xo.uvlMocr IA3B'bH cpoKa Ha nepvlo.qr4rrHr4Te .qocraBKr4 .Eo 2 (lea) pa6orHr EHrA.TlnannnvaurramA \.{y e BaJryrIHo .qo 04.08 .2016 t.

Kolqcrasra cqrltrar He o0epEatra rra yr{actngrtKa orroBapg Ha r4b%cKBarrr4rrtra HaBrgnoxzeen,f,. 9r ,qonycKa cEl4ara Eo oldextrBaae ,r KJlacrpaHe.

3. ,,MEIEKCZ OOIYqacrHurctr o$epl4pa r43n'bJrHeHr4e flpe.qMera Ha nop'bqKara Ha cJre.uHyrrerAk2n.maAuv n^aEyKTrAt llo KoI4To e lonycHaT .qo yqacT'.le:

onM

NC

son

ATC NNIle(apcrBeHa

QopMa

HA ATUEHOTO

nexapcTBeHoEeqecTBo

npor{o3HuxongqecTsa TrDroBcro HanM€HosaHf, e

Epoi B

f,p9AnaraflaraonaxoBka

nphroxaron Ha palpeu6Hhelo 3aynotpe6a

CpoK Ha

or nPY -

2 3 4 5 6 7 8 I 10

3. Axrr6axre pnanHr neKapcrBa 2 360

3 2 J01C1102Amoxicillin/Clavulanic acid

tabl. film -coate0

875mgl125

mo500

Climoxfilm-coated tabl875mol125mq x 14

14,,9afiraQapuaBhcororaqecreeH utefleraocrea"Afl

2

3 3 JO1 DDOl Cefotaxime

powder forsolution forinjection/infu sio n

1g 40

Cefotaxime-Tchaikapharmapowd.for sol.foriniectionlqxl

1

,,ulafixaSapriraBucororaqeqreenureflexapcrea"A.Q

2

3 I JO1 MA1 2 Levofloxacin film-coatedtablets 500m9 80

Levor 500 mg film-coated tablets x 10

10,,9araxa$apnltaBuco xo xaqesreeH hreflexaocrea"AIl

4

4. flexapcraa 3a neqeHre Ha cbpAeqHo-cb4oBrl3a6onFBaHHc 5 280

4 8 c03cA01 Furosemide solution forinjection

10mg/ml -

2ml1 200

FUROSER10mg/ml solutionfor ini. 2ml x 10

'10,,9auKacpapMaBh coxoxaqecreeH ilreIexaocrea"A.[

4

6, flporlreoeb3nan hrerHH neKapcrBa 2750

6 1 MOlAEO3 Ketoprofen solution forinjection 100m9 200

KE I UPKUFEN-TCHAIKAPHARMAsol.for inj.1 00mq/2ml x 90

90,,t{aixaQapuaBucoxoxa.{ecreeH uteIexapcrea"A!

onNe

NcBon ATG NN

,lexapcrBeHaQopMa

KonHtecrBoHA AThBHOTOneKapcTBeHo

Beqe6TBO

lMrpIal

nporHosiF{otrttecTa

aTLproEc[o HanMeHoBaH6e

B

npeanaraH

aTaonak

npureMren fla pdopeueHhero iaynorpe6a

CpoK HatoAHocTor nPY -

B

toahHu

2 4 I 10

1 . Axrurpou6orrqnr nexapcrBa 5 900

1 1 BOlABO5Enoxaparinsodium

sol. inj.,pre-filled

syr.

4000lU/0,4m1

500

CLEXANE 100 mg/mlsol.for inj. (pre-filledsyringe) 0,4 ml x10

10 Sanofi Aventis

1 2 BO1 ABO6 Nadroparin solution forinjection 3800 tu 1 600

Fraxiparine 9500 anti-Xa lU/ml sol.foriniection 0.4 ml x 10

10Aspen Pharma TradingLimited, Vlpnangna

I 3 BOlABO6 Nadroparin solution forinjection 5700 tu 200

FRAXIPARINE 95OOanti-Xa lU/ ml sol.forinietion - 0,6 ml x 10

10Aspen Pharma TradingLimited, Vlpnan4ua

J

2.Vn$ 314OHH14 pa3TBOp9l 14 600

2 1 BO5BAl O

Ol. Olivarum 15 %Amino acid sol.6.3%,+E: Glucosesol.1 8.75%

emulsionfor infusion

2000m1 100Periolimel N4Eemulsion for infusion2000 ml x 1

1 Baxter 2

BO5BBOl

Electrolytes(lVa0nesium chloridehexahyd16te 0,39;Sodiumchloride 5,269; Pot€sslumchloride 0,379;Sodiumacetate trihydrale 3,699;

Sodium Gluconate 5,029/l

solution forinfusion

tPH7,4t-1000m1

3 000Sterofundin ISOsolution for infusion'1000 ml x 1

1 B.Braun

3 BO5BBOl

Electrolytes(N4agnesium chloridehexahydrate 0,39;Sodiumchloride 5,269; Potassiumchloride 0,379;Sodiumacetate trihydrute 3,689iSodium GluconaLe 5 02oll)

solution forinfusion

tPH 7,4t -500m1

4 000Sterofundin ISOsolution for infusion500m| x1

1 B.Braun

4 B05BC01 Mannitol sol.for inf.100g/l-500 ml

2 000MANNITOL BAXTER10% solution forinfusion - 500 ml x 20

20 Baxter

5 v06Dc01Glucose/Sodiumchloride

solution forinfusion

50 g/9g/l -

1000m1500

GLUCOSE 5% +

SODIUM CHLORIDE0.9% BMTERsolution for infusion -1000 ml x 10

10 Baxter

2 7 B05CB01 Sodium chloride sol.for inf./glassi

0,9o/o -250m1

2 000

SODIUM CHLORIDEBMTER 0.9%solution for infusion -250 ml x 30

?n Baxter

3, Anru6axrepuanHH neKapcrBa 2 360

3 J JO1 DDOl Cefotaxime

powder forsolution forinjection/infusion

1g 40

CEFOTMIME-TCHAIKAPHARMAoowder for solutionforiniectionlo x1

1 Tchaikapharma 2

5 JO1 FA1 O Azithromycin tabl. film -

coated500m9 70

AZA trlm-coateotablets 500 mq x 5 5 Nobel Pharma 2

J 6 JO1 GB03 Gentamicin solution forinjection

40mg/ml-

2mlJCU

GENTAMICIN-VETPROM sol.inj. 40mo/ml-2ml x10

10 Vetprom

3 11 JO1 XBOlColistimethatesodium

powder forsolution for

InJ. orinfusion

lMIU CU

Colistin Alvogen 1

MIU oowd.for sol.foriniection/infusion x 10

10 Alvogen 2

4. flexapcraa 3a neqeHhe Ha cbpAeqHo-cbAoBH3a6onFBaHhc 5 280

4c01 BB01/NO1 BBO2 Lidocaine solution for

injection20mg/ml-

10ml 1 000Lidocaine Accord 20mg/ml solution foriniection 10 ml x 10

10Accord HealthcareLimited, O6e4nneuoKpancTBo

z

J c01 BD01 Amiodaronesolutio for

intravenousinfusion

bUmg/m -

3ml120

Cordarone solutionfor intravenousinfusion 150 mg/3 mlx6

o Sanofi Aventis z

4 o c01 DA02 Glyceryl trinitratesolution for

infusion1 mg/ml -

50ml 60Nitroglycerin PH&T 1

mg/ml solution forinfusion x 50 ml

PH&T 3

4 8 c03cAo1 Furosemide solution forinjection

1U

mg/m -2ml

1 200FUROSER 10mg/mlsolution for injection2ml x 10

10 Tchaikapharma

5. fl porneoeb3nanHTerHra H o6es6onsBaqhfleKapcTBa

6 1 MOlABO5 Diclofenac sodiumsolution for

injection75mg/3m

I750

NAKLOFEN 75 mg/3ml solution foriniection x 5

KRKA 5

5 MOlABO5urclolenac;Orphenadrinecitrate

solution forinfusion

75mg/30mg

250m1.500

Neodolpasse 75mg/30 mg solution forinfusion 250 ml x '1

Fresenius Kabi AustriaGmbH

5 3 AO3ADO2 Drotaverine solution forinjection 40mg 2 500

NO-SPA 20 mg/mlsolution for injection2mlx25

25 Sanofi Aventis

5 4 N02BBO2Metamizolesodium

solution forinjection

1000m9/2ml 4 500

METAMIZOLESODIUM-VETPROMsolution for injection500 mo/ml 2 ml x 10

10 Vetprom

5 5 N02BE0 1 Paracetamol solution forinfusion

1 000m9/100m1

250Paracetamol Kabi 10mg/ml solution forinfusion 100 ml x 10

10Opeeeruyc Ka6nSunrapnr EOOI,Sunraorr

15

6. f'lporreoer3nafl HrenHu neKapcrBa 2750

6 1 MOlAEO3 Ketoprofensolution for

injection 100m9 200

Ketoprofen -Tchaikapharma 100mgl2 ml solution foriniection x 90

90 Tchaikapharma 2

f,

7, AnrrxetuoparhqHh H aHThaHeM,rqHr nexapcrBa 380

7 J B03AC06lron (lll) -hydroxide dextrancomDtex

solution forinjection

50 mg/ml-2ml 100

COSMOFER solutionfor injection 50 mg/ml-2ml x5

5 Pharmacosmos 25

vr{acTHI/KbT npe.qJIarla cpoKoBe 3a Ti3rrbJIHeHIA e Ha nop.br{KaTa: npv neprAol.u\tHu.qocraBKI4 .qo 10 (.qecet) pa6olnu EH'IA ol ro.EaBaHe Ha 3a.qBKara, npr4 Bb3Hr4KHaJraHeooxo.4l4Mocr Il3BbH cpoKa Ha nepzo.qr4qHr4Te .qocraBKtt .qo 3 (rpm) pa6ornm EHIA.flpeg.noxeHr4erlo My e BaJn4.qHo .uo 04 .08.20 16 r'.

Kour,rcugna Konctra J]II

Crve vDe uo,qoyadHlle 7 KaK['o cJre.UBa: Sodium chf oride/ Potassium ch]-oride/Magnesium chforide hexahydrate/ Cal_cium chloride dihydrate/ Sodiumr'al- ^]- a tri hrzrl 1319/ l,-Malic acid v cborBerHo PH, KoI4To He orrroBap.qr Hau! rlr y v.

l.l3r4CKBaHI4ETa Ha BTT3JIOXI4TeLq/ 3aJIOXeHtI B CneqmQmrcauylqTa.Ha ocHoBaHrre FoperagJroxeaotro w no pega Ha qn. 59 | ail.L | tr. 3 otr 30II /KoM%ct4gtra qpetrJrara o(lepgara rra ytractrHurKa ga 6tge otrcEparrega otr' yr{actrr4e BqPoqetrlrpatra rro cJreEHgttre HoMeltKJratr]rptt or o6oco6eruase rLog.wrJryr: NsM 2.2. ;2.3.IIo octranaJrr4tre :tolteHKJratryplw otr, o6oco6erurre raoBwJW I Kovrzrcrzanr.a ctirr4tra, 9€o(Deptratra rra l ractrHnKa onroBaprr :ra w3.z,c.KBanyrstla rra Beb,noxyrre,ns u ,qonycKaCrEl4aBa AO OI{eHtIBaHe U Kfiac,I,IPaIte rIO trtlx.

4. /,cboH%Kc eAPIVIA" EOOAVu:nmurrprm arhonrznr r/enrnua'rr,^-\yepl4pa l43rrbJlHeHl4e npe.qMeTa Ha nop.br]KaTanAkrn.mPAuv n^ailyKTr4t llo KoI4To e .4onycHaT ,4o yrJacTl4e:

HA afranHT/mo

,l{e npe,EJIoxeHI4Te o qa HI4KA

2 2 BO5BBOl

Electrolytes (Magnesium chloridehexahydrate 0,39;Sodium chloride 5,269;Potassium chloride 0,379;Sodium acetatetrihydrate 3,689; Sodium Gluconate5,029/t)

solutionfor

infusion

IPH 7,41 -'1000m1 3 000

Sterofundin ISOsolution for infusion1000 ml x 1

B.Braun 3

2 B05BBOl

Electrolytes (Magnesium chloridehexahydrate 0,39;Sodium chloride 5,269;Potassium chloride 0,379;Sodium acetatetrihydrate 3,689; Sodium Gluconate5 02olll

solutionfor

infusion

tPH 7,4t -500m1

4000

Sterofundin ISOsolution for infusion500m| xl

1 B Braun

onN9

NOEon NN

nekapcrseHaqopMa

KonttecrBoHA ATHAHOTOnexapcTBeHo

BeqecTFo(MrpE)

npoaHo3HhaonttectBa TrDroBcto hatMeHoBaHHe

6poi snpeffar

AHATAoIa(oBx

npurexaEn Ha pa!peueHtero3a ynorpe6a

Cpok HaI oAHOCToJ nPY -

rOAH HU

2 3 I '10 11

1. Axrrrpou6oru.rnu neKapcrBa 5 900

1 1 BOlABO5Enoxaparinsodium

sol. inj., pre-filled svr

4000lU/0,4m1

500KIIEKCAH AMN.4OMT 0.4Mfl X 1O

10 SANOFIAVENTIS

1 2 BO1 AB06 Nadroparin solution forinjection 3800 lu 1 600

OPAKCNNAPTHunPilu AMn.0,4MI X 10

10GLAXO SMITHKLINE

I 3 BOlAB06 Nadroparin solution forinjection 5700 tu 200

OPAKC]4NAPTHunPhLlAMn.0.6Mn x 10

10GLAXO SMITHKLINE 3

1 5 BO1AB1 2Bemiparinsodium

solution foriniection 3500tu 100

31450P 3500 0r. X2

2BERLIN CHEMIEMENARINI 2

2. rAnd t3140HH14 Da3TBOpt4 14 600

2 5 v06Dc01Glucose/Sodiumchloride

solution forinfusion

50 g/9gil-

1000m1500

UEPYM IJItUKUStsl/Ho. P-P 500MrlBRAUN 3641216

B.BRAUN

2 6 B05CB01 Sodium chloride sol.for inf.(LDPE)

0,9% -1000 ml 3 000

HATP14EBxIoPhA t4HO.P-P0,9% 1N BRAUN3641202

I B.BRAUN

2 7 BO5CBOl Sodium chloride sol for inf./glass/

0,9% -250m1

2 000HATP14EBxItoPr4A yrHo.P-P0,9% 250MI

1 B.BRAUN

EPAyH 3641200

3. Anrr6axre puanHu neKapcrBa 2 360

1 JOlAAO2 Doxycycline caps. 100m9 600 floKc14UilKn4H](AflC. 100urX6 AK

ACTAVIS 4

J01 CR02Amoxicillin/Clavulanic acid

tabl. film -coated

u/bmgl125

mo500

AMOKCI/KTIABTAEII. 875vr/1 25urx20

zv SANDOZ 2

J 3 JOl DDOl Cefotaximepowder forsolution forini./ infusion

1g 40qEau tAKUvrM-Mnn on. I rP1sMI X 10

10 MIP Pharma z

3 5 JO1 FA1 O Azithromycin tabl. film -coated 500m9 70

ASATPI4IITAEII.500Mr x 3

ACTAVIS z

b JO1 GBO3 Gentamicin solution forinjection

40mg/m -

2mlJCU

fEHTAM14tjl/HAMf]. 80nar2unX10/KYT]4FlBETNPOM

10 VETPROM

J 7 JO1 GB06 Amikacin solution forinjection

500 mg/2ml - 2ml 250

cEnEMhr_lt4HAMN. sOOMT 2MIIx10

10 MEDOCHEMIE

8 JO1 MAO2 Ciprofloxacin tabl. film -coated 500m9 320

LlnnPfiHoJr TAEn.500Mr x 10

10 KRKA

3 10 JO1 XAO2 Teicoplaninpowd.andsolv. for

sol.for ini.400 mg 50

TAPTOLI14AOII.4OOMT XlIKYTVIFI

1 SANOFIAVENTIS 3

4. flexapcrea 3a negeHhe Ha cbpAeqHo-crAoBl43a60nf,BaHh9 5 280

4 c01 BD01 Amiodaronesolutio for

intravenousinfusion

50mg/m -

3ml120 KOPAAPOH AMN.

1 50u13nrtnX6/ryrnr/o SANOFIAVENTIS z

4 c01 cA04DopamineHydrochloride

concentratefor solutionfor infusion

40 mg/ml-5ml 100 EOnAMhH AMn.

4OMilMIIsMIIX 1O10 POLFA

I c03cA04 Torasemide tablet 10 mg 450TOPCt/IT SRTA5I|. 1oMr X 30

30 UNIPHARMA

I 10 c03cA04 Torasemide solution foriniection

20 mgl4ml 300

TP14OAC AMN.20Mr/4Mn X 5

BERLIN CHEMIEMENARINI 3

4 11 CO3CA04 Torasemide solution foriniection

10 mgl2ml

1 000TP]4OACAMN.1OMil2MIIX 5

BERLIN CHEMIEMENARINI 5

5. flporreonb3nanHrenHh u o6e36on.FBaulhneKapGTBa 8 500

5 'l MOlABO5Diclofenacsodium

solution foriniection

75mgi3m750 AIIMI4PAI AMN.

T5tvr13nnX Slxwunl 5 MEDOCHEMIE

5 MOlABO5Diclofenac;Orphenadrinecitrate

solution forinfusion

75mg/30mg

250m1.500

HEOAOflnACEcofl.250MIl 1 FRESENIUS KABI 1

5 AO3ADO2 Drotaverine solution foriniection 40mg 2 500

HO-UINA AMN.4Ourl2unX26lxwus zc SANOFIAVENTIS

5 4 NO2BBO2Metamizolesodium

solution forinjection

1 000m9/2ml 4 500

AM143OIIMETAMN.sOOMT/MII2MII X1O

10 PHARMA SWISS

5 5 N02BEOl Paracetamol solution forinfusion

1 000m9/100m1

zcv ilAPAqE TAMUJIlOMilMIIX 1

1 FRESENIUS KABI 2

6. poTxBoEb3narrHTenHH J|eKa pcTBa 27506 1 MOlAEO3 Ketoprofen solution for

iniection 100m9 200 nPooEHr4A On.100Mr t.v. x 1

SANOFIAVENTIS 3

o , MO1AE17 Dexketoorofen solution foriniection 50mg 2 500 AEKCOOEH AMn.

xstKwvifll 5 BERLIN CHEMIE 5

6 3 MOlAH04 Parecoxibpowd. and

solv.forsol.ini.

40mg EAAl4HACTAT OIr.40ur 2MIl+PA3TB.xltKyTnflt

1 PFIZER

7. Anrrxeuoparni{H 14 u aHTHaHeMrqHH fl eKapcrBa 380

7 1 BO2BAOl Phytomenadione solution forinjection

1Omg '160K(JflAKvtUfiAMN.lOMilMIIlMJI X 5

ROCHE5 J

7 B03AC02Saccharated lronOxid

solution foriniection 100m9 120 L1AAOEP COfl.

100Mr /5MI X 11 VIFOR

Tzl T'TT-T n m arTl [To Q .fvfttr'v.

8. flpyru neKapcrBeHn npoAyKrr H3BuH flpunoxexne 2 xa I1IC 17 7SO

N9 nopea NN KonuqecTBo

anMBHO AeUlefrsO,le(apqsera

Q0pMa

npofto3Hg

(onIceqBA

npox3aoA[rer TLproEc(o HauMeHoEaBhe PeflcrpaquoHeH BoMep

upo( HaroaHocTor nPY -

B

6 I I

1 Ambroxol uumg/cml-100m1

syr OU NOBEL PHARMAAMEPEKC C14PON30Mf/sMlt150MIl il-1 0628/07.09.201 0

2 Amoxicillin 1000m9 tabl. 720 SANDOZAMOKC'1K'IABTA6II. 875MT/125MTx20

ll-1 0628/07.09.201 0 z

3 Barium sulfate 1 009 pulvis 100 MhnBE A.q EEKA-EAP NPAX XlOOTP MilNBE 111476129.01.2008 r z

4Betamethasone (asBetamethasonediorooionate\

0,05% x15g

ont zvSCHERINGPLOUGH

ArnPo3oH yHrB.1 sTP

20020271 5

5 Bisacodyl 1Omg supp 30SOPHARMA PLC,Sofia

6143AKOA14rlcvno3.1oMrx6 ll - 15378t28j2.2006 3

Carbaethopendecinebromide; Boric acid;Sodium tetraborate-decahvdrate

10ml orops eye 30TEVAPHARMACEUTICALS

OOTAflMO-CENTOHEKCKOII]4P lOMII

9700448 2

7 Chlorhexidine 0.1% 115ml DU 40 AKTAB14C-OTC

cEnTAA14Hcor.0.1% 11sMrl

Ne ll-0248t17.07.2007

2

8 Chloropyramine 1% - 189 ont 30SOPHARMA PLC,Sofia

AIIEPTO3AH YHTB.1 8rP

Ne I- 2974 I16.09.2008

Y Dexamethasone 0,25m9/g -32,50q

spray JUPOLFATARCHOMIN

[EKCAnOnKOPTcnPEtt32,50rP il-10720t25.04.2005

2

'10 Dexketoprofentrometamol

25 mg tab 300BERLIN CHEMIEMENARINI

AEKCOOEH TAEfl.25Mr X 10

200108262

11 Dexpanthenol 50mg/g -40o Yv 60 AKTAB14C-OTC

I tAfl tut EJt I EJI 5%40rP 20020476

2

12 Diazepam 1Omg tabl 1 300 AKTAB14C AA AhA3ENAM TAEII.10Mr x 20 20000442

13 Drotaverine 40mg tab 200 SANOFIAVENTIS HO-UNA TAEJI.40Mf x24 20130292

14 Ephedrine 50mg/ml-1ml amp. 30

SOPHARMA PLC,Sofia

ts(PEAr'y|FlxLrAPOXn. AMn.sOMT l MII XlOIKYTIAFI

200301 26

15 Etamsylate250 mgl2ml

solutionfor

iniection2200 OM PHARMA

l.ll/il_lyrHL)F| AMr r.

25OMT 2Mfl X4/ONAKOBKA/

200305505

16 Ethacridinelactate0J%-1000m1

60 Xt4MAKC P]4BAHOII1fl X 0897 t19,10.20071

17 Ethanol 7Qo/o -1000m1

200 X14MAKCCNhPT ETI4IIOB70% 1n /0.800KT/ x 3622t28.11.2008

4

18 Ethanol 95% -1000m1

SU 800 XhMAKC UI IYIPIEIYIJIUB95% 1n /0,800Kt-/ x 3717t05.12.2008

19 Fluconasole 100m9 caps. 300 AKTABUIC AA AYHI UJIUII KAI IU.100MTX 16

N9 il-3488t13.11.2008

20 Gentamicin 0,1% - 15 g cream 10 AKTABLlC AA TEHTAM14U14HKPEM 15TP

20010257

21 Hydrogen peroxide 3"h -1000m1

so 80 Xt4MAKC KLlCJIOPOAHABOI1A 3% lIIX 4154t05.02.2009

1

22 lodine 5%-1000m1 10 Xt4MAKC T-PA r4OA 5%1 000Mfl x 4153/05.02.2009

1

23 Lactulose 679/100m1-15ml sacn qFn MYLAN AyoAJIAK CAulETl4

1sMfl X 1020000353

24 lavandulae oleum1o/o -1000m1

SU 30 Xt/IMAKCCNhPTflABAHAYIIOB0,800Kr x

3621t28.11.2008

25 Lidocaine 10%-389 spray 20EGISPHARMACEUTICALSL

nilAot(Al4H CnPE1410% 38TP

'13685/27.06.2006 r.

zo Loperamide 2mg caps 1 800 SANDOZ Jrur rEllvrvM KAr ru.2Mr X 10

2001 08305

27

Metamizolum 19,Fenpriverinibromidum 40mcg,Pitofenonihvdrochloridum 4mo

2m amp. 150SOPHARMA PLC,Sofia

CNA3MAITOH AMN.2Mfl X5/OnAKOBI(A/

2003057S

I

28 Miconazole20 mg/g

4Oo oral gel zv JOHNSON &JOHNSON C.H.

AAKTAP]4H OPAIIEHrET 2OMT/TP 40TP

20011071

8

29 Naloxone 0,4m9/ml-1ml sol. inj. 40

POLFAWARSZAWA

HAflOKCOH AMP.O,4MilMfl X,IOIKYTVIFI

200301 664

Neomycin 11,72 mglg-32q spray 30

POLFATARCHOMIN

HEOMt4rjl4HyMcnPEtt 32rP 20030373

2

JI Nimesulide 100m9 gran, 250 BERLIN CHEMIEMENARINI

H14ME314JI TPAH.100MT X 15

0549/05.09.2007 r.

JZ Norfloxacin 400m9 tab 2 200 KRKAHOnilLlhH TAEfl.400MT X 20

20000707

33 Otilonium bromide 40mgfilm-

coatedtablets

650BERLIN CHEMIEMENARINI

CNA3MOMEHTA6fl.4OMT X 30

20060747

34Oxytetracycline;Hydrocortisone

9,30 mg/g+3,10 mg/g- 32,25 g ml

cutaneouS

suspenslon

30POLFATARCHOMIN

OKChKOPT CNPEt432.25fP |-8241t17.11.2003 z

Paracetamol 500m9 tab 2 000 ADIPHARM LTDNAPAUETAMOIITASI 500Mt- X 20A-NYIOAPM

il-1 1 385/1 2.08.2005

Retinol;Ergocalciferol; Cod-liver oil; Peru Balsam;

350ru/4001U/gxl 89

ont 150SOPHARMA PLC,Sofia

EEOITAMOfl yHrB.18t-P

20050502 2

37SaccharomycesBoulardii 250 mg capsures 800 BIOCODEX EHTEPOfl KANC.

250Mr X 10il-5839i 1 7.09.2009

3B Senna glycosides 75ml SO 20 MUNDIPHARMA X-NPEN OII.75MII 24282t25.11.2013 1

Suxamethonium 10 mg/ml -5ml

amp. 1 700 NYCOMEDPHARMA AS

JI14CTEHOH AMN1% sMIIX5/OnAKOBt(A/

ll-0971/01 ,11,2007 z

40 Validolum 60mg tab 200 FARMAKBAfl]4AOfl T46I.6OMT X 20 OAPMAKtPvcKVll

ll-4163/05.02.2009 z

41 Zolpidem 10 mg tab 700 SANOFIAVENTIS U I YIJ II1UKU IAbJ I.

lOMTX7 20000531 4

Yrracrnzrctr npe.uJlarra cpoKoBe 3a vr3rrbJrHeHrze Ha noptrrKara: npv nepuoEuuHrl.qocraBKI4 .qo 10 (Aecer) pa6orHvr E]ts-vr or ro.EaBaHe Ha 3a.EBKara r npw Bb3HL,rKHaJraHeo6xo.U4Mocr t13B'bH cpoKa Ha nepr4o.ErzqHr4Te .UocraBKr4 .Eo 3(rpz) pa6orHr4 AHvr.TlnonnnxaHT/amn \,4y e BaJrr4.qHo ,tro 04 .08 .20 16 r'.

Kovlrcrasra yctranoBr! :1 n^^r . rryuAJruaE nvL>tT olI' yqacTHI4Ka JIII 3a I{3[BJIHeHI4e Ha HoMeHKJ]aTypeH Ns 2 .5 .

CEPyM IJII0KO3E llH@. P-P 50OMJI BRAUN 3641216 He cborBercrBa Ha r43mcKBaHeroHa Br'sroNlarer,q 3a KorrrlecrBo Ha aK['tIBHoro J]eKapcrBeHo BeIIIecrBo (rr,rnprca ) or50 q/9 q/t - 1000m1;'2 . llpe.4loxe:g,ufl.r or yqacrHlrKa JIn or nPy B. BRAUN sa r4srrbJrHeHr4e Ha*ot"**r,"TVDeH Ne 2.7. H; c'boTBeTCTBa Ha lrgrrcKBaHeTo Ha Brsroxr4reLq .Ea 6T).!,eB OnaKOBra glass;3 . flpe4"noxeHr4Te or yqacrHr4Ka JIll 3a r43n.bJrHeHrze Ha HoMeHKJrarypHr4 NeNe 3 .2 . ;3.5.; 3.8. He Smlyprpar n IIJIC - lIpvtn.2, aK[yaJreH KBM rarara 20.04.2016| . | IlOCor{eHa B O6,qBIeHI4eTO 3a nopbriKaTa, C npe,UJ]OXeHI4Te TbprlOBCKr4HaI4MeHOB aHr4s. v npr4TexaTeJrTr Ha Pa=peueHr4eTo 3a ynoTpe6a (llPy) | aBg:,noNzteJI.sr e galtl4caJI Karo 143r4cKBaHe B .qoKyMeH[' arJvrflTa ro npoqe.qypara :

,,flpegloNeHIzre reKapcrBeHrr npolyKTrr Ea Qrlypupar n llo=vt,tvtzuws. JreKapcrBeHcr',rcbK (llnc) - llpz.rtoNeHt4e 2. ".4. 3a OII Ns 8:- npe.qJloxeHr.qT oT yrlaCTHyIKa JIll 3a yISrIbJIHeHI4e Ha HoMeHKJIatypeu Nr B . 1 . e C

KOJlr4qecrBo Ha aKTT4BHOTO BeUIeCTBO OT 150 Mrr a Br=nOXnreIgr e WSrLCKaJr rrocneqr.rQrnauvs. I00 un;- npe.qJIoXeHI4.FIT OT yrlacTHI4Ka JIll 3a J43[bJIHeH]4e Ha HoMeHKJIaTypeH Ne B .2 .

Ar,rorccunnae ra6n . B'7 5ttr' / !25tttr. , He orroBap.s Ha yravrcKBaHoro or Brg.noxv rer.q -AworccmqxnmH 1000 rurr,.Ha ocrroBanrze ropergnoxenono vr. no pega rra r:n. 69 | alr.L I l' . 3 otr SOII ,rcovrucwztla rrpegJrarra oQeprara Ha yqactrHr4Ka Aa 6ege orctr'panena otr yr{actrr4e B

Epolle,qyPatra rro cneAgtrtre HoMeHKJratr]rprd on, o6oco6erryrre r:oE.vtrJryr: NsN! 2 .5 , ;2.7.; 3.2.; 3.5.; 3.8. u rto On Nr 8.

IIo octranaJrrtre HoMenKJlal"ypll,t otr o6oco6errylre l:oBl'z;,ln:z I r.orquc;wrula cr{rtra, H€o(leprara r:a yqactrrrraKa otrrroBaps :ra rgrrcKBagr4rrtra Ha Br5.noxlrrens u Ao[ycKactsu{atra go or{eltrrBarle w KlIac.rtr'pal{e rlo Errx.

5. //QAPKOJIU A,qVu:amutzp,rm ndranrzn: T/enrnua'rr,^-\yepl4pa I43rIbJIHeHr4e npe.4Mera Ha nop'bqKa['a 3a cJIe.4H]4Tenokrn.mEAul^ n^aEyKTrAt rIO KOI4TO e .4OnyCHaT .qO yqaCTI4e:

onN9

N'Bon NN

,leKapcrEoHaQopMa

KonugocrBoHA ATilBflOTOne(apdseHo

BeqocTEo(MFPXA'

nporHo!HHaonxtecTBa TtproBcxo Haf, MeHogaHile

E

npeanaraH

araona(oBxa

np(Tetaren Ha pa3peueHuoro3a ynorpo6a

CpoK HaroaHoctor nPY -

aroauHl

2 3 5 6 1 I 10 11

1. Anrnrpou6orrqnn neKapcrBa 5 900

1 4 BO1AB1 2Bemiparinsodium

solution forinjection

2500tu 3 500Zibor 2500 solutionfor injection 2500 lUanti-Xa/0.2 ml

1

Menarini lnternationalOperationsLuxembourq

2

2. HnSysronHlr pa3rBopr 14 600

2 4 BO5BCOl Mannitol sol.for inf.1009/l-500 ml

2 000Manitol 15 % B.Braunsol.for inf. 1509/l-500ml

1B.Braun Melsungen

AG, Germany

2 6 B05CB0 1Sodiumchloride

sol,for inf(LDPE)

0,9% -1000 ml

3 000

Natrium ChloridBraun 0,9% solutionfor infusion, 0,9% -'1000 ml

1B. Braun Melsungen

AG, l-epnranr,tr3

3. Anrn6arrephanHH neKapcrBa 2 360

3 1 J01AA02 Doxycycline caps. 100m9 600DOXYCYCLINACTAVIS hardcapsule 100mq x6

Arrasnc EA,Q,

6rnrapun 4

3 JO1 FA1 O Azithromycinpowder forsolution for

infusion500m9 50

Sumamed powder forsolution for infusion500mo

1 Pliva Ljubljana d.o.o.

3 5 JO1 FA1 O Azithromycin tabl. film -coated 500m9 70

AZAX film-coatedtablets 500ms x5 5

Ho6en Qapua OO,Q,Suraou.s

3 6 JO1 GBO3 Gentamicin solution forinjection

40mg/ml-

2ml350

Gentamicin Vetpromsolution for injection40 mq/ ml - 2ml

1 Berflpottit A,[

3 7 JO1 G806 Amikacin solution forinjection

500 mg/2ml - 2ml 250

Selemycin solutionfor injection/ infusion500 mq/ 2ml

1Medochemie Ltd.,Knnrp 15

3 8 JO1 MAO2 Ciprofloxacin tabl. film -coated

500m9 320 Ciorolon tabl. film -coated 500mq x10

10Hikma Farmaceutica

(Portuqal), S.A.,fl-n 3

3 I JO1 MA12 Levofloxacin nlm-coatedtablets

500m9 80Leflox film coatedtabl. 500mq x7

7HOEEII OAPMA

OOII Ernrapr,rn 4

3 11 JO1 XBOlColistimethatesodium

powder forsolutlon for

InJ. Or

nfusion

lMIU 50

Colistin Alvogenpowder for solutionfor injection orinfusion l MlU

Alvogen lPCo.S.ar.l,Luxemburg,Ircxceu6ypr

2

5. flporreoeb3narHTenHH H o6es6onflBalqyrneKapcrBa I 500

5 MO,IABO5Diclofenacsodium

solution forinjection 75mg/3ml 750

Naklofen solution forinjection 75 mg/3 ml

1

KRKA d.d. Smarjeskacesta 6 Novo Mesto,Slovenia

5

5 2 MO,1AB05

Diclofenac;Orphenadrinecitrate

solution forinfusion

75mg/30mg

250m1.500

Neodolpasse 75mg/30 mg solutionfor infusion 250 ml

1

Fresenius Kabi Aus-tria GmbH, Hafner-strasse 36,A - 8055Graz, Austria

1

5 J AO3ADO2 Drotaverine solution foriniection 40mg 2 500

NO-SPA solution foriniection 40mo

1Caxodh-AeeHrIcEunraouc EOO-[ 5

5 NO2BBO2Metamizolesodium

solution forinjection

1 000m9/2ml 4 500

Amizolmet solutionfor injection1000mo/2ml

1

PharmaSwiss CeskaRepublika s.r.o.,9euxa penv6nuxa

5 5 NO2BEOl Paracetamol solution forinfusion

1 000m9/100m1

250Paracetamol Kabisolution for infusion10 mq/ml - 100 ml

1Opeaennyc Ka6raSrnrapnr EOO!, 5-n

16

10

71 JIII oI OT NS 8 :

8. flpyru fleKapcrBeHh npoAyKrt4 h3BbH flprnoxenrae 2 na flllc 17 750

Ne nopea INN

KonlcecrBoanlBHo seqecTB0

tle(epfrBeHa@0pMa

TlporHo3HH

xonx9ecTBA

npor3BoAHrcn TbproEcxo HatrMaBoEaHuePerucrpaqhoHeH

HOMEP

roaHocTor nPY -

2 I I

Ambroxol SUmg/5ml-100m1

syr OU6anxanSapnita AynnuqaM, Eunrapnr

Mucolisin 30 mg/5 mlsvrup- 100m1 x 1

PR1 05095 z

2 Amoxicillin 1000m9 tab 720Astellas Pharma EurooeB.V., The Netherlands

DUOMOX 1000 tabl.disp. 1000 mo x 20 RR 1 07807 5

Barium sulfate 1 009 pulvis 100 "(D3 Munee" A.qDC-BAR-MILVE 90 goowder for oral and rectalsuspensionl00qxl

R301 266 z

4

Betamethasone (asBetamethasonedipropionate)

0,05% x15g

ont 20Schering-Plough LaboN.V.,l Belgium

Diprosone 0,05%ointment 159 x 1

RP'1 05159

5 Bisacodyl 1Omg supp 30 COOAPMAAABISACODYLSOPHARMA suppository10mqxG

R301 1 67

o

Garbaethopendecinebromide: Boric acid:Sodium tetraborate-decahvdrate

10ml orops eye 30Teva PharmaceuticalWorks Plc, Godollo,Ynrapnn

R302880drops solution 0,2 mg/ml+ 19 mg/ml + 0,5 mg/ml -

10ml x1

7 Chlorhexidine 0j% 115ml 40

Sanxar$apura Tponn A'Q,6tnraons

SEPTADIN oromucosalsol 0.1% 1 15 ml R301 808 z

8 Chloropyramine 1% 189 oint 30Co$apua A.Q yn.l4nuencxo uoce 16, 1220Codnn. Sunraohq

Allergosan 1% ointment1g/1009 -'189 R30251 7

9 Dexamethasone 0,25m9/g -32,509 spray 30

TarchominPharmaceutical Works'Polfa'S.A. Poland

DEXAPOLCORTcutaneous spray, 32,509

RP1 02956 z

10Dexketoprofentrometamol

25 mg tab 300

Laboratorios MenariniS.A., c/Alfons Xll, 587, E-08918 Badalona,Barcelona, AcnanuaCamoo di Pile hranun

Dexofen @ 25 mg Film-coated tablets 25 mg x 10

R302373 2

11 Dexpanthenol 50mg/gl-409 60 Eanxan$apua-Tponn A.Q Pantogel gel 40 mg x 1 R302434

12 Diazepam 1Omg tab 1 300Eanxan$apura - EynnnqaAn Fr,nranuc

DIAZEPAM ACTAVIS 1O

mo tablets x 20RR1 05699

13 Drotaverine 40mg tab 200 fuuQapu EM DRO SPAZ tabl.40mgx20 R300932

14 Ephedrine 50mg/ml-1ml

amp. 30CoSapua A.[,yn."k'lnuencxo Luoce"'1 6,1220 Cocoaf,, EunraprR

EPHEDRINESOPHARMA 50mg/ml-1ml sol.for ini.

RP1 05624

15 Etamsylate 250 mgl2ml

solutionfor iniect

2200 Sanofi Winthrop Industrie,Ooaxuus

Dicynone 250 mg/2 mlsolution for iniection

RP1 05361 5

'16 Ethacridinelactate 0,1% -1000m1

60"Kynpo 94" OO[, fopnaOpnxoauqa, Eunrapun

SOLUTIO RIVANOLIKUPRO 0.1% cutaneoussolution 1.0 q x 1000 ml

R301 928

17 Ethanol 70% -1000m1

200 "Kynpo 94" OOfl, fopxaOpnxoeraqa Eunrapun

Spiritus aethylicus kupro70 per cent vol./vol.cutaneous solut 1000 ml

R301 753 2

18 Ethanol 95% -1000m1

SO 800"Kynpo 94" OOE, fopnaOpnxoeuqa Ernraprr

Spiritus aethylicus kupro95 per cent vol./vol.cutaneous solut '1000 ml

R301 755 2

'19 Fluconasole 100m9 caps. 300EanxanQapua Pasrpa4,Br,nranLrc

FUNGOLON caps.100mox16 RR1 01 780

20 Gentamicin 0,'1% - 15 g cream 10SanKaHQapMa Paarpa4A.[l, SunrapnR

GEN IAMIUIN AU IAVI!i1 mqiq cream 15 q

PR1 051 08 3

21 Hydrogen peroxide 3o/o -1000m1

so 80Kynpo 94 OOA l-opnaOprxoenqa, Eunrapnr

Hydrogen peroxide kupro3% cutaneos solution 10mlx1000 ml (p-p sa xoxa)

R301 81 4 I

22 lodine 5%-1000m1 so 10"Kynpo 94" OOA, FopnaOpnxoeuqa, Eunrapun

SULU IIUN IUUISPIRITUOSA KUPRO5% cutanefus solution500 x 1000 ml

R301 925 1

23 Lactulose 679/100m1-15ml sach 350

Solvay PharmaceuticalsB.V. . The Netherlands

Duphalac 67 g/100 ml -15ml x 10 sach.

R300227

z4 lavandulae oleum1o/o -1000m1

SO 30 "Kynpo 94" OO,Q, l-opnaOpnxoenqa, Eunrapnr

SPIRITUS LAVANDULAEKUPRO 1% cutaneoussolution (pasreop aaroxa) x 1000 ml

R301 932 z

11

25 Lidocaine 10%-389 spray 20EGIS PharmaceuticalsPLC. YHI-API4F

LIDOCAIN spray 10% -38sx1 RP1 0 1 833 5

26 Loperamide 2mg caps 1 800Salutas Pharma GmbH,Germany, Lek S.A.,Poland

Lopedium capsule 2 mg x10

R302767 5

27

Metamizolum'19,Fenpriverinibromidum 40mcg,PitofenonihvdrochloridLrm 4mo

2ml, amp. 150 cooAPMAA.q

SPASMALGON 5OO

mg/ml +2mglml+0,02mg/ml solution forinjection 2 ml

RP1 05628 5

28 Miconazole 20 mglg4og orar gel 20

Janssen PharmaceuticaN.V,Turnhoutsweg 30 B-2340 Beerse, Eenrun

Daktarin 20 mglg oral gel4og

R302806 3

29 Naloxone 0,4m9/ml-1ml

sol.inj. 40 Warsaw PharmaceuticalWorks Polfa SA, Poland

Naloxon WZL 0,4m9/mlsolution for iniection

RP1 04853 4

Neomycin 11,72 mglg-329 spray 30

TarchominPharmaceutical Works'Polfa'S.A, Poland

Neomycinum TC11,72mglg cutaneousspray, suspension 32 g x1

RPI 051 54 z

?.t Nimesulide 100m9 gran 250

Helsin Birex,Pharmaceuticals Ltd.Damastouwn. Mulhudart.dublin 15, l4pnanars;

Aulin Granules for oralsuspension 100 mg x 27 RP1 05462 5

32 Norfloxacin 400m9 tab 2200 KRKA, d.d. Novo Mesto,CnoeeH14n

NOLICIN film-coatedtablet 400 mo x 20 RP1 051 92

33 Otilonium bromide 40mgfilm-

coatedtablets

650Berlin-Chemie AGMenarini Group,Germanv:

SPASMOMEN 40 mgfilm-coated tablet x 30

RR'109827 3

Oxytetracycline;Hydrocortisone

9,30 mg/g+3,10 mg/g- 32,25 g ml

culaneouS

suspenslon

30TarchominPharmaceutical Works'Polfa'S.A. Poland

OXYCORT 9,30 mg/g+3,10 mg/g cutaneousspray, suspension - 32,25oml x1

RP1 05566 2

35 Paracetamol 500m9 tabl 2 000

Sanxan$apnra - fiynxnqaM, yn."Cairoroecrouoce" 3, 2600 lynnnqa,Srnraoilc

Paracetamax tablets 500mgx20 R302691 5

Retinol;Ergocalciferol; Cod-liver oil; Peru Balsam:

350tu/4001U/gx189 oint 150

CoQapua A.Q yn.l4nnencxo woce 16, 1220Codun, 6unraDuR

Deflamol ointment 350lU/400 lU/g x '189 R30251 I a

37SaccharomycesBoulardii 250 mg capsutes 800

BIOCODEX, 1 avenueBlaise Pascal- 6000Beauvalis, Opanqun

Enterol 250 mg capsulesx20 R302794 J

38 Senna glycosides 75m 20 Mundipharma GmbH X-prep sol. - 75 ml R300333 z

39 Suxamethonium10 mg/ml -5ml amp 1 700 Takeda Austria GmbH,

AustriaLYSTHENON solution foriniection 10 mq/ml - 5 ml

RR1 02951 z

40 Validolum 60mg tabl 200Oapuax - Sunrapnr OO!- Sunraohc

Validol 0,06 g sublingualtablets x 20 R301 483 2

41 Zolpidem 10 mg tab 700Sanofi Winthrop Industrie- Tours. ODaHunF

Stilnox 10 mg film-coatedtablets x 7 RP1 05273 4

Y.{actFIt4rc't'l npe.EJIarra cpoKoBe 3a I43n%JIHeHI4e Ha nopbrJKara: fipvr rrepuoEIruHvI.qocraBK]4 .uo 1O (Aecer) pa6orHvr EHrA or no.UaBaHe Ha 3a.cBKara, tpv B.b3HilKHaJraHeo6xo.q]4Mocr ir3B'bH cpoKa Ha nepr4o.qvrqHr4re .qocraBKr4 .qo 3(rpr) pa6ornr EHvr.flpe4roxeHrrero My e BaJll4EHo .qo 04.08 .2016 t.

Kolaacusra KoHctratrrrtr)a / qe npeIJIoxe:r.vrfl.r or yrJacrHr4Ka JIll ga 143rIbJIHeHr4e HaH^\trAHknam\/naH NTs 2.4. - Manitol 15 ? B.Braun SOl.for inf. 150g/I-500 ilf,He cborBeTcrBa Ha l43I4cKBaHeTO Ha Btg.nOXrren.g 3a Koru.{ecleo Ha aTl4BHoT'oTroT4,1nr-mReH1.1 Rorrro/-mRa) r/nlsnr: ) ^- l Ann / l _tr,nn ,1f .uvqvvfuv LvvYl

Ha ocHoBaHere Foper4gJro)KeHonro w rro pega Ha 'rn. 69 | arn.L | tr'. 3 oE SOII ,rcoL,tuc;ayrtEa rrpegrara o(lepratra rra yr{actrHrrKa Ia 6'gge otrctrpaHega otr yr{actrr4e Brlpoqegl4)ara rro rroMerrKlratnypa N2 2.4.

IIo octraaaJrtrtre rroMeHrcJrarryp.w otrr o6oco6erurre r:og,wrJryrt Kouytclvrillla cslrtra, E€oQeptratra Ha yqactrHr4Ka otlroBaprr rra rrBtrcKBaar4rrtra Ha Brgrroxyrreng w go[ycKacrEr4aEa go orleHrrBaHe w KJracypaHe lro trrrrx.

L2

Kouucrcsroa onPefleJrtl ,qatra I qac w MEctro ga otrBaprrne rlenoBrdre o(leprla HayrlacrHI4UI4Te flo o6oco6eHlare no3I"LrJwvr I tro KoI4rIo ca ,qonycHar]z .qo orleH.qBaHe uKJIacI4paHe - 25.05.2016 tograaa, on 09.00 rraca/ B rca6uHera rra VrrpaarareJrrr Ha,,KOll-Eypractt EOOI B rp. Byplac, 6yn.CreQan Ctala6onon,, Ne 13, XzpyplmueuKopnyc rta MBAJI-Eyplac A!, erax 7.

Kotrytcun:TJnannanaman.rlyv4vv4u r vu1 .

9neHoee:

/ 4.W!WnnVEd,/

/ tt ttamnnP: // H. rrv Lrvusl

/v.xoen/

/A.AB.qxmeBa/

/T/'Pananapa /, zr. LvFvyv,J4r

?

4

wL

-f.ti-t FAr-l\J t.qFU FIHI-\. -F>PPirFiI !.!.lL-J> .A.

wv(rl . YI=EEFli

F'

=\f\

13

NPOTOKOJ] N9 3

[Hec, 25.05 .2016 rlo.qr4Ha/ B 09.00 qaca, s ,,KOII-Byptac" EOO,U, e rca6yrHera Ha\/-^--"-^ -- -.KC)TT-Frznnar-// Ernf\ n - Tna.. nn Frznr: a 6ttn t'cmar\=rJrr'Pd'rrvr.J-'uJr.H' fld. IIUUA, Ha dAr--. *r.-r y--ct UyJI . U'I'eQd.HCrav6onoB" Ne 73, Kortlyrcw+ B cbcraB:

llpegcegaren: lapzHa Cro.qnona - rrJr.Me.U.cecrpa npu ,,KOIl-Eyplac'/EOO,U;Vneuoee:1. .[eaua llerpona - npaBocnoco6eH rop]4cr no rur.14l a.n.5 ol 3OII;2. Mmuxo Koen - cr.eKcneprr,lrperqza "3llC.UT3C", O6uyrna Eyplac, no .ur.I4tar.5 or 3OI];? Tlrr:u: AnnvrrogS - HaqaJIHI4K orIeJI , P3II Eyplac, lto rrr.14, aJ].5 or 3oil;;4'L!4LtllrI!g/r\,r\

4. IApuna Toropoea - Marll4crbp-OapMaueBT, 6orHu.rna anreKa Ha ,,KOU - Eyplac"EOOL

B l43n'bJrHeHr4e Ha 3anoBeI Ne 103 or 04.05 .2016 Ha Vlpaevre.nR Ha "KOII-Ftznn:c// E'nnTT -a aeAn: nnanrFvr, ^Dn dm. nrAamr f,^Lve/1t ue cj'buljd Jld npo.qbJIXI4 cBOH'-r'd. pduo,1'd rro pd3-r'Jle2KAdhre r

oueH.qBaHe rr KJracr4paHe Ha |IocTbn]4Jrr4Te ooepTr4 3a yrracTl4e B o6rlecTBeHanop'br{Ka - orKpr4Ta ilpoqe.Eypa/ c npe.4MeT: ",{ocTaBKa Ha JreKapcTBeHr4 npo.uyKTylro npl4JloxeHa c|Ierll4o*urcagvtn". IlpouelypaTa e oTKpzrTa C Peuesre Ne

09/14.03.2016 r., perll4crpr4HaHa e AOII nog Ne 00232-2016-0003, ny6rr4KyBaHoo6.cBreH'.1e B POI] Ns 179 318/14.03.20L6 I'. vr e OB Ha EC Ne 2016/S 055-091550/18.03 .2016 r.

llpegcega['er.cr Ha KoM]4cr,r.cra npoBepr4 cbcraBa Ha npyrc'bcrlBarrr4re u cJre.q KarloycTaHoBI4, rle npr4cbcTBaT BCvIl{KtA rlJIeHoBe Ha KoMyIcI4fl.Ta, oTKpm 3ace.UaHI4eTO.lIr er.on2ur/amA Ha KOMI4cl4.sra He npilcBc['Bar npe.ucraBIA|IeilI/r Ha yr{acrHI4I-l]4Tet4rfi[ EpyTvl [paBor4MarlTr Jrwr],a.

I. Kot"gttcwzwa r4)I4ctr'tlnBa KEM otr'Baptllle Ha llexoBrrtre qpeAJroxegzrr rrayr{actrHr4r{lrtre, rlo Pe,qa Ha uoctt'rBnBalte tta o([eprvfiEe wMr.

1 . ,,COCAPI"IA TPEftIIHHr " ]l'q- ooepra ex . Ns OI / 28 .0 4 .201 6 r' .

Kottsacwg,na o['Bap.c v onoBec['.rrBa r-leHoBI4Te npelroxeHl4.q Ha yrJacrHI4Ka rrooT.qeJTHl4 apTr4KyJrr4 JreKapcrBeHr4 npo,qyKTr4r [o KorlTo rlo e EonycHaJ]a .uoATTAuopau^ r^ vnac]4paHe.'rnrznr: ^m unaH^BeTe Ha KOMI4CI4.qTa nO.qnfCBaT UeHOBIZTe npe.qIOXeHI4.g.IIounp'mo nna rrIOXeHtr4g 3a OT.qeJIHylTe JIeKapCTBeHI4 npO,EyKTIt Ce OII4CBaT Brrrvfrv

m^<-,",,- 1lctuJll4l-ld II I1trJ]4JIOXeHa KbM HaCTO.SUI4fi npoTOKOJI .

2. /,TtsPIOBCKA JI'IrA HAII\\ A,q - ooepra nx.Ng 02/04.05.2015 r'.Kol"fl,rcil.cra orBap.q v onoBecr.cBa IleHoBr4Te rtpe,uJ]oxeHrz.g Ha yr{acrHI4Ka roOTAeJIHI4 apTIAKyIIt/I JIeKapCTBeHI4 npo.4yKTI4 r [O KOI4TO rro e .UOnyCHaJ]a .qo

^TTAUqEAHA f^ vnacl4paHe,Tnnrr:

^m unaH^BeTe Ha KON1;,, 1gIAfl.Ta nO.qnI4CBa[' U6HOB]4Te npe.qIOXeHI4.q.

TTaunpvmo nno nr- --r -fi-IOX.eHIAA 3a OTIeJIHUTe JIeKapCTBeHfi npO.UyKTI4 Ce OnilCBaT Bn-^-.-,,- 1'IaoJrr4u,a r I npr4JIoxeHa KBM HacTo.rrur4.s npoToKOJI .

3. /,MEAEKC'/ OOI - ooepra Bx.Ne 03/04.05.2016 r'.Kotr,rzcr,t.qta orBap.rl u onoBecr.qBa rleHoBI4Te fipe,qJ]oxeHr4.s Ha yqacrHt4Ka flooT.4eJIHI4 apTI4KyJrm JreKapCTBeHl4 npo.qyKTr4 r [O KOTTTO rlo e .4OnyCHaJ]a .qOn TTaHqR:Ho rn vnac7lpaHe.ITrnunr:

^m unaH^Bere Ha Ko\rMCwATa no,utll4cBar rIeHoBl4Te npe.uroxeHl4.q.TTapnprzma rna nr- --r--n.IOXeHr4.s 3a OTIeJIHT4Te JIeKapCTBeHr4 [pO.EyKTI4 Ce Onr4CBarl B

Ta6lrua 1, nprzJror(eHa K.bM Hacro.qqr4.s nporoKor.

4.,/cboHI{Kc eAp}IA\ EOOI - ooepra BX.Nq 04/II.01.2016 r'.Korr,tvt clzgla orBap.c u oroBecr.qBa rIeHoBr4Te npe.uroxeHur.s Ha yrJacrHr4Ka nooT,qeJIHI4 apTJ4KyJII4 JIeKapCTBeHr{ npo.uyKTr4 r [o Ko.gTo r1o e .EonycHaJIa .uoorleH.sBaHe 14 KJIaCnpaHe.Tpmva or rJreHoBere Ha Ko\nyrcrrfr.Ea no.qilr,rcBar IleHoBI4Te npe,qJloxeHt4.rr.TTor+nnrzma nna nn,.r--4"IOXeHI4.q 3a OT.qeJIHI4Te JIeKapCTBeHTI npO,4yKTr4 Ce Orr4CBaT Bm^^-,",,- 1rauJu4qa tt [pr,lJIoxeHa KbM HacTo.qu]4.q npo['oKoI .

5 . ,f eAPKOJI\\ AI - ooepra ex . Ns 05 / 1,I . 0I .201 6 r' .

Kotrtvtcws.ta orBap.rr u onoBecr.rrBa rlenoBI4Te npe4roxeHl4.q Ha yqacrHI4Ka rlooT.ueJIHI4 apTI4KyJrr4 JreKapCTBeHyr npo.qyKrur r [o KosTo r1o e ,EonycHaJ]a .uooueH.EBaHe 14 KJracr4paHe.mhr,",-'IpI4Ma OT rrJIeHOBeTe Ha Kor.ltyrcrAAra no,Errr4CBaT rJ,eHoBoTo ripeIJroxeHr4e.TTounprrmo nna nr..r--A"roxeHI4.q 3a oT,4eJrHI4Te JreKapcTBeHr4 npo.qyKTr4 ce oflilcBaT Bm-4.-,-,,^ 1l d.uJu4rld ! | rltrJJ4JTO)KeHa KbM HaCTO.qUII4g IpOTOKOJI .

II. Ha 6asa HaneceHr4tre B Ta6nraqa 1 egurrurrHrt r{eHu rra otr,qeJrnyrtre JreKapctrBeHrrEPOAyrCtrtr4 B O6OCO6erUare ll.og,wlJpIu I r.otquc',4f,lria rlPr4ctrErrBa Ktbllt cPaBrrrrBal{e rtaoilepl4>arutge otr yr{actrttr,fllt[Ee e+yrgtvrt{rrv r{eltyt I c t/r3vrcKBaHJ4.qra Ha Br3noxrreIa,rocor{eHr4 B IoKyMeHTaur4.qTa 3a yqacTr4e B npoqe.qypaTa:1) ,,3d JreKapcrBeHrare rlpogyKtrrr otn o6oco6erua nosynJryt orr N 1 go Nt 7BKJrtotiIr4IreJrHo: . , , llpegnoxeHara or yrracrHl4Ka e.ql4nr4rrHa qeHa cJIeEBa ,Ea HeHa,qBI4IxaBa c'borBerHara crorzHocr Ha JreKapcrB envr+ npo.uyKT B no3vrrvrBHvr+JreKapcrBeH cnrrctK - llpr,iron<eHr/re 2t aKTyaJreH KbM.Uara - 20.04.2016 t.";2) ttel.rAHn.]Hara r-leHa Ha npe,ulalaHnre JIll Ea 6r.qe 3aKp.brrJreHa .uo BTopr4H 3HaKcJTe.q .uecertlqHara ganera.q, a 3a JIn e ra6nerHa Qopua - .qo rrerBbprrr.c 3HaKcJle.q .EeceTZrJHaTa 3aneTa'I.Axo TTeHoR.'tfF.l rrnATTTTnv.FrJT/o r-{a \/rJaa-rFHT/T{e HF c ofrronvter+o (qaxnr-FTTFH-\ nOllyvAurvJllvllJfvvvYvyf'r

- TrrA 6+-na ^T..mpaHeHO OT VrlaCTl4e B npo11e11vpaTa nO 'gela Har qv vDAv -'-''paHeHo oT yrlacu4e B npoqelypaTa no pe,4a Hi,tI.69 | alr.I I r. 3 or 3oll , Karo HeorrloBapsqo Ha fipe.qBap]zreJrHo o6.qBeHr4Teu3vrcKBaHtt+ Ha Bg=noxmreIrA. "

I-J: ^r-H^RrHT/a naHHI4Te e Ta6.11l4qa 1, K119tg;34tltra KOHC1ja11r14pa Cnefl;1otrO:

1. 3a yuacrHr4Ka ,,COOAPI'!A TPEIi[nHf'f A.[:

rlnonn:r:uvma a\wHvru-Hvr UeHr4 Ha oQepl4paHI4Te JIII c.gotneTct'Bar Ha I4gI4cKBaHI4.sraHA B'b3JIOXI4TCJ],9.

2 . 3a y'racrHuKa ,,TbPIOBCKA JII4IA IIAII\\ A,[:

flpeEnar,aHara e.qr4HTrqHa ueHa Ha nocoT-reHr4.q B cJre.qBarqara ra6Jlr4rla Iil HaEBvrrraBacboTBeTHaTa cTorzHocr Ha c,bt]{.ufl. e IIJIC, T.e. He oTrroBap.s Ha il3ilcKBaHeTo HaBrsJroNmrens, rjr4Tr4paHo e r'.II. 1) or Hac['o fli]Jvrs. nporoKoJr:

Kor"vtcwzra EpeAJrana o(lepratra :ra ylracrgetKa sa JIII Nt 3.2. ga 6rge otrctrpageHaotr Epor{eflypatra, Ha ocuoBanue trn.69 | ar.7-t o.3 or' 3OIl .

,

onNE

NC

onATC NN

HA ATHBHOTOne(apcTB€Ho

aeqecrEo

9pok naroAHocfor nPY -

l-leHa 3aONAKOBK

a c,[.!C

J 2J01 CR02

Amoxicillin/Clavulanicacid

tabl. film -coated

875mgl125

mg500

Climoxfilm-coated tabl875m9/125m9x14

14,,9ailxa$apnaBucoroxaqecrsIerapcraa"Afl

z 0,8886 12,44

3. 3a ytracnHtaKa ,rME,{EKCrt OO[:

flpeg"nalaHara e.ul4HurrHa ueHa Ha nocoqeHr4lr B cJre.qBarlara ra6.nurla JIII Ha.uBr4uaBac'bo['BeTHara crolZsoct Ha C'bulwfl. e llJ]C / T . e . He orr'oBap.s Ha r43r4cKBaHero HaBt3loNmre,[.{, ]-UlrilpaHo e r. II.1) or Hacro.cqr4.c nporoKoJr:

Kololcragra rrpetrnara o(lepnara :ra yqractrHetKa ga JIII N 5.5. ga 6rge oncrparrerraotr qpoqeglrpatra, rra ocnoBan%e trn.69, afl.L, r.3 or' SOII .

4 . 3a y'eacrur4Ka ,,ebOHtlKC €APMiA,/' EOO,[:

flpe4la|aumre eAIAHyTHHTA UeHr4 Ha nocoLleHr4Te B cJre.qBarqara ra6nmqa JIIIHA rTRT/TTIA R^ rF r-q.)T'BeT'HaT'a CT' OrHOCT Ha CbIIIIZTe e IIJIC r T . e . He OTrrOBap.qT HarA3ucKBarero Ha Bts.noNmrerx, Ur4Tr4paHo e r'.II.1) or Hacro.srlt4.s nporoKorr:

Kovnacuzra qpegnana o(leprrrtre Ha yqacEnraKa ga JIII Nt 3.3. , JIn N 5.1. tt sa JIIINs 5.5. ga 6rgatr otrcrpageHlt otr Epor{eA}E)ara, rra ocnoBanrae trn.69, an.L, s.3os 3OII.

5. 3a y.racrH,r4Ka ,TQAPKOJI'' A.[:

rh^FF---rrrn-rrllsAJrolqnara c,r{TIHI4rfHa l-leHa Ha IIOCOrleHTl.q B CJIeIBalqara fa6"nuUa JIll Ha.qBI4[IaBacborBerHara crotauocr Ha c'bnlrtfl. e IIJIC I T' . e . He orroBap.q Ha r43rzcKBaHero HaBr:.roNmrerx, ur4Tr4paHo n r. II.l-) or Hacro.qulr4.q nporoKoJr:

Kouucrasra Epe,qJrana o(leprara rra yiracrHrlKa Ba JIII N 5.5. ,qa 66Ae otrcrpaHeHaotr qpoqeg]T)atra, rra ocrroBaar4e tr.n.69 | alr.Lt r.3 or SOII .

III. Kot'snc;mcEtrna qpr4ctrrBrlBa KrBM KJracr$)aHe na qpetrJroxeHugtla lta yriractrHr4rlrrtre,Aonycxatr% Ao orleHsBaHe u rcJracrttr)aHe I Karo 3a UeJrra oQoprrlx Ta6nmqa Ne 2 ,HAn^ a na nH^ u:.T oT' HacTO.EIII4.S ilpOTOKOI .

3

onN!

Ng

aon

NNtlexapcrBeHa

QopMa

KonrqecrEofrA AIHBBOTO

neKapcTBeHoBeu'lecTso

nporHorHHxonuqecTs

a

TLproscxoHAUMEHOAAHf,E

Epoi rinPean.

ONAKOBKa

nphroxaren BE

pa3peueffuero 3aynorP€6a

Gpo( HaroaHocTor nPY -

B

Eauruqna

nocoqeHaTaunpxa c,[.{C

LleHa 3aONA KOBK

a c !.qC

5 5No2BEOl

Paracetamol

solutionfor

infusion

'1000m9/

100m1zcv

ParacetamolKabi 10 mg/mlsol.for infusion100 ml x 10

10

Qpe3eHnycKa6u EtnrapunEOOA,6unraouc

15 1,49 14,90

onN9

l.le

n

NNnelapcrEoHa

QopMa

HA ATtrBHOTOnexapcTBeHo

B6U'leCTEO

nporHo3HtrIonutecTs TrproBcxo

HarMeHoaaHu€

Epoi snpeAn.

onaaoBx

np[Texaten Hapa3pou€Htoro Ja

ynorpo6a

Gpox HaroAHocTor nPY -

EAIHhcHa

nocoqeHaTaMqpKa c AAC

LleHa 3aONAKOBK

a CAAC

J 3JO1 DD

01Cefotaxime

powoerfor sol.for

ini./ inf.1g 40

l_lEooTAKc14M-MfiN Ofl. ,1TP

1sMIt X 1010 MIP Pharma 27 27

5 1MOlAB

05Diclofenacsodium

solutronfor

iniection75mg/3ml 750

AIIM14PAIIAMN.75MT3MIIX5/KYT14F/

5 MEDOCHEMIE 0,64 32

5 5NO2BEO

1Paracetamol

solutionfor

infusion

'1000m9/

100m1250 NAPAUETAMO

JI IOMT/MJI X 1

FRESENIUSKABI

z t. tv

onN9

Nco

onATC INN

tle(apctB6HaQOpMa

HA ATNBHOIOneKapcTBeHo

BeqocrBo

nporffo3H,xonhqecE

a

TLproecxoHAgM€HOSAHh6

Spoi snpeAn.

onakosxa

npurexarei Hapasp€ueHueTo 3a

ynorp€6a

Gpox HaroAHocTor nPY -

B

EAHHtrcHa

noco9eHaTaMqoKa c AAC

L{eHa 3aONAKOBK

acE4C

5 5No2BEOl

Paracetamol

solutionfor

infusion

1 000m9/100m1

250

ParacetamolKabi 10 mg/mlsol.for infusion'100 ml x 10

1

ape3eHhycKa6n StnrapnnEOO!,Brnraouc

16 '1,33

Ha ocHoBaHI4e I43BbptlleHoro ra B c'borBercrBl4e c u3rrcKBaHufl.Ta Ha ,an.'7 I, aJr.5otl 3OII/ KoMI4cI4.sra Iqe npoBele ny6nmvuo xpe6nil. Ba olpe.qer,rrHe Ha rr3nbJrHyrreJrMex.Ey KJIacI4paHI4Te Ha nbpBo M.qcro oQepru , rl'.ilt Karo Kpr4Tepr4ET B Hacro.silIarao6ulecreeFla ilopbqKa e ,,Hailt-urrc:r'a qeHa" vr ra3rl qeHa ce flpe.qJrala B .qBeadronmrz ar -nanLv\yelrryr oo uurs,r-1rIl4Te JIeKapCTBeHI4 |IpO.qyKT]4:

4 t c01 BB01/NO1 BBO2

Lidocaine solution for injection 20mg/ml-10m1 1 000

4 c01 BD01 Amiodarone solutio for intravenousinfusion

50 mg/ml-3ml 120

/ c01 cA04 Dopamine Hydrochloride concentrate for solution forinfusion

40mg/ml -5ml 100

8 c03cAo1 Furosemide solution for iniection 10 mg/ml - 2ml I 200

5 AO3ADO2 Drotaverine solution for injection 40mg 2 500

Kot'plc,vtgna onpegeJrtl gatra, r{ac u Mfrctrro ea ny6nztlno npoBexAage Ha ape6rrZ -03 . 0 6 ,2016 r'ogttrra, oE 0 9 . 00 qaca, Er Ka6rlnetra rra Vupaelauenz rra .KoII-Etrpnac'/ EOOA, B rp. Eyplac, 6yn.CreQaH Crav6oloe,, Ne 73, Xr,rpypluveH KopnycHa MBAJI-Eypr,ac A.[, elax 7.

Kot,Jvrcws.:TJna nno na ma n .r.rvsvvAg l I .

tlneHoee:1

/ tt I mAduADa /t F. v t v.LLLV Ds /

/ A . lleTpOBa/

/v.xoee//fl lF-"'"'.^-^ // A. ^DAAyr-DA/

/ yL. tvAv[,vDa/

9Jrt-i-{ Rl\J bq

l=l Fi; t:€tP7=:Fli{ tl.''!LI7Fl

(JJtiYv>(i=5>-- )1

R'1

lYl

--(E

o.co

a f.. st'i

f.*

+f--

O)O)o.i

NO.N

@tir@_

N oi@- cf)(o

nllr)vlf)A

N.N N

N

c\F- Nq

so) lir

N.

@t-d$ N

N{scu)

s

--fnt+1

|F

3

t.l

\,\l.a

-(

tF

=

HRr

-fn

-IIJFtrTl,rJotrtu.to-E

Sos=o

qov(L

o

Nct)

os.

f)r)\ Nlo

ni

@

qN

oNc)-

Nt-s

sry

o,@.

N

os-oJle

(J

@-c)

(JON@_

N $

OLO

+

Uvv_

t\(osc\l F-

N

osc)-

otr)-

s ^ic.)

oYIJJtE

o

c)

oof'-f.--N

c.)ryv oO

o(o(oce

s@.N

oO)\:N

Lc)

c.i

O

A NN

:z

8s9=Irf

co@@.

NN.N

@c)o{

=o-

o

ooNf--.ct)

oF-6i s

f.-

$

loc\to

ooc)o

Nc)-s

ibF 6 6 6 F 6 6 F K s 6 6

H;eiSEgI

o

o

s

sF

to

Fs

5lee

d

ls B

so

$

s

os(r)

sN

E

I

7

e

EF

ER11

EB

EE

EI6

EcK

(5oF

GEo)F

sIoso(l,F(!los

ct

I

E

&

E

E

f;ER

E

E

e

EcE

f;

ER

E P

c =

!

H

FE

{

:

T,:I.9

t

x.E

e

=3

9E:d

eg

.9

d'a

.9

Ie,E

!E

.9

.E

I

3

.9

3.g

e

t

.qE,aI

cs

,E

e3

I8

!c

E

5I

e.9

66xe

*

tEE

5!

ed:-5

5s

e.0.';Eg3

Eq

E

E! E :!

z=

E

!oc'cooouJ

.EoIp6z

'EG

Y!6z

E

E

'E6.gEo

Ef

'E6oEo

o

;iul+

;<c?qoE

Go

E

so

--x>\

-7

o

xE _9

Xf,:'E i;--o6s,pb-go* uf_Py,

'ioPo! oRFQ=x'= Y o{+r'"N-:EO.ii.=Eo58,9 696Yc^u 6s'0lg o_ o_ _=UOOU

o

;o.sx 5;'P n6_ar 6o€Xq)o* f; x'>s N-E

9{:ii5E E s=b:s5P.9 6E6Y:Fo oN ylgo-o-=

o=cc6

oEosE

Eoooo0

o'tro!

E

=o

0)

6E

e=

o.cEa

o

oocof6

C)

.c

XoE

OE'x6.oo

'o

EIN

IEE

=N

C:qcoco

c(!:E

'oo

e.s

E

6X

bc)J

c'-oo'6L

E-6

po0E.9

F@

@

@

o

@

@o@

o@

NE

o@

N6

o@

ooo

E@

o

@@a@

oooo

oo@

o

m

o@

oo

No N

t oooo

oIo

6@

o

o

N N NoX

ooxo

i'[ N N o o N O o @ r N o o @ N o

E2 N N N N N N N o o 0 o O o o

6o(\trtoouJ

of,o-

r.o

f

:

TSF:a

trtoo-Es-IJJo-OlrJqN

s=!zsesTutEo

s\aE]

I

I

I

l

lI

t1HL

tvlFN

HFi

H--\t

F

trsos=o:a

6oal

trtooIJJ

ofl(L

r.o{o=

IsIqo(LEsIUJ(nF

uJqolGsf:zstts:JIJJr()

oqE

(lt

q,<

$so.i

Nf.-d N

c!O)v-cf)

tf)

Aro, co

@c\l

NcN

v O)-@cf)-

sv. (f)sN

@ c.lc)

F--@t-.N

@.i:

qoo-

e

v N@ c)

$.

osIoJIe

ot-A

ooc\{

f.-co-

lirO)-

\r@"

o@N.

ovc).

oN$.

O

I@N.N

olr)N

o$\ N

oYlrJtrIIJJ

=

sN

It-@

@O)-

@

Ns"

cof.-

vc)_ s v O)t- i=

vF-t\

8sYSTF

rf) N

=o-

goo

s \rni

t-_

ory

\ir \t vO)-

(oo).

Ov@

cf)

Nt-.O

t-_N

f6 6 6 R I 8 6 6 6 R 6 6 K 6

! eiH'9 E:9 e 6i

E'Ei

s

F

(o

ms

J

oo_J

(,so(1,

(o

F

q)

t

Ec

Ei

ER

EI

E

E

E

e

E

E

E

EqEE

E

E

€E

E

E EqE

oF

oq,qs=ooqtoo\o

ssI

o,

s(E

oJods

E(t

EqER

E

E

EsE

EIE

oo(J

oYoF

s-ps-t!oTo

soEG;

EI E E9

(!

Fo(oYo-sE

soosF(!ssTsdoq)xsF

L

E E

E

EE

3

:

f;a:

I:e

€t

.9E

E4

€5

.9

E.ge,9

t

e.9..=

.953

_9

E,g

e.95T

E E

E6

.9

:

t

.9

T:-e.9

t

J.g€

5

:qI

t

F

i';e

5

J

€.95

fi5-

g

6':e

E3

-EI

E

.9

T'ie.95B

zz

'xo'-

o

5op

ocIo

E

o!

=0ED

o.cE6oo

oc.EEocuJ

agcEEC)

(1

o.Epc-

O

Eoo5

o

Eoge

o

Eog

-

o

Eooo-

E.f

aooc.obpo

og=o.E

FcoE

o-6.0)bpo

oc'trooE

E

Eooo.NE6b

oEabgo(L

c.0)

IaoY

a

IobvXOo

Y(!

Oc.oocoEoE

X

!oIGc

oU)

o

EoogEoDopoE

=o

ooo 9R

;6rE6z

ooo

q(-)

N

o (-)

No0 o

aO

oo oN

oN@@Noz

oUmN

z

ourU

o

3I ?

mNo

N

@

@

o@

i 'I N N o $ @ N o o N o o N o N o

F2 $ s v n @ a o o @ @ @ r N N

quJFtrtUJ(JtrtuJ(LE

{:r\\aI

i>,J H

<-)=mfmX<t7FE<<r]

lrlaIFfFt -

(v')

i

II

II

uJFtrIIJJotrtuJ(LE

-sosEoY

(J

Eotro(l,

ry$

t-

\r.

f.-q(o

(oN.$

@(o-

O

C9

sF-aro

c!cr)

t-f.-

t-t-()o

c.)F-N

-i

ro(o

CD.

(.os.N

o)

@

cr)

Cr)

l^c)t\-rr) C.)

c.i

@(Y).

N

sto

l^c)q$N

(of.-O)_

$-@

\t"o)

ss.

N

-

qoYo-

e

N\r

Nlif N

@N.s

c.)

A cr)

Oot-s_ N

ot--N

F-f.-rorl)o

@.

IoNA

Cf)w-N

Nols s

(ov.l.c)

(-)

ni

J

li

o@_

cr)

r.c)tr).@

F.cr) v-

O)

vv N

ovSIoJIe

ToIo

5-o

o:auJ(IJJ

E

I

I

Y8r9=

f=o-

eoo

ib6 r 3 6 g 3 R 6 6 H d

oqEo

(\,1

os

FsE

J

ssY

otrsoF

o-c)

sL

trI-i

F g 7

III 3 c g E E 3 3 I

3

E

E 3 3 3 3 E 8-3

E^;6

id

EFEgEe

E

I 6

a

I E I

EflgE E

R

IE E EI

E

iEI

E

E

3

EI EI

ER6

aE

E E

E

E8b

E6 3

E E

z=

E

E

.c

oE4

0).o

=oE'Eoco

oo.9

e.go

6

oEoo

oocG!oEGom

!ooo.9.c0

E.=

oEo.9o

opE

!igoOq=iEE*sgqE

tocia

c).CExosota)

o.FeE

I=

oco(!

ocxoo

;EabEtrcoY

o

o

oc0)

oXoo

EaoN.6o

o'Eo(!Y

o.E

o

ul

q)

o=Eo

UJ

os(to

=.E6EuJ

6!UJ

;ccul

o

ocol

c

Eocoo

opxIa)

oIT

o.E

_9

o

EE6J

Eo

oolEc6o

o.Eo

=

q)pEEo

J

ooEo

EpEp

.Es>E

oou=o8s9.J!

NbSE>ii

o

z

N o @ ts @ o q o @ ts o oN NflN N N

@N

F

6o(\

ooIJJ

of(L

r.o

=to:TSF

trtoo-EsIIJJ(DFoo-

!zuJ

5(\

sf

SesJIUEo

-

fvlra

F

F-L

F

E4-

Fitn,<r.

4

Hp-=fn

;sos=o

6o(\trtooIJJ

ot-o-

to-ro:

EsF

trIoo-Es-IJJoFoo-

YllJ5NqsJYsesJlIJ

o

qIIJFtrtIJJotrtIJJo-E

oqE

(I,

o,{

N.(rJ $ (J

lir

O

oF-No

cr)F-\t,

lr) sCY)-

LJNO

o

Ut--r{)

N\N

NO)

A

gJvo$.o

((:rs\aF

co(L

e

st-

J)

vf-NA

(o|f)ro

A

osc?

Nf.-_

lr)$-

Nf-.-N

CY)

No)

o

sot

o!ZsIoJTe

To(!

o-

oYultrTlrJE

z,isJS

!

=o-

ooo

:3ib6 d a 6 H a

oqEt!

N

sqt

rs-ossF

o

sIoo(J

ooIsL

trI

Ea

:d3

+c

!

E

E

s

8-IgI

gE

L3

3 E !

EN

e

E

E

E

E

gE

[. E E

c $

gE

?

ER

a

?Iffi

P

RE

E

E E E

z=

-qN6

o

=

o

X

6z

'o

Eoz

o

f

o,Ez

ooEz

opee

c.l

oEo.9.E

YET

iDc

9.Eo

c0)

go

H6

.9.od)lO

=6T

E.0)'6(!ooPuJ

ocot

E6

c)

EEoEo

opooE)6co

E.looEoxl

E

6p6

Eo

=N

d

olz

N oN

No a @o tso 6o o

cnEquOhKAHHF 2 -nEKAPCTBEH14 nPOAyKT]4 HA "KOq-6yprAC"EOOE - 2016r

TbPTOBCKA II]4TA

Olivarum 15 %,Amino acid3%,+E: Glucose so|.18.75 %

lu

5. fl porn aoeu3nan t4Ten HH H o6es6onsea qH neKapcrBa

KOMhChfl : NPEACEAATEN

3,.\ JIUTIE IIA I4H (D OPMAUI4^fl Iro PEAA HA 3 3 Jr tr

cnEqhohKAqt4f, 2 -nEKAPOTBEHt4 npOAyfil4 HA "KOq-EyPFAC,'EOOA - 2016r

, AnruxeuoparHqHH h aHTlaHeMt,t9H]4 neKapcrBa

lron (lll) - hydroxide dextran complex

1 g, Fenpriverini bromidum

KOM14CHfl nPEflcEIATEII I

3 AJIHqE I{A I4TI O O P MAIII4 ^,I rro PEi {A rrA 3 3 Jr /I

IIPOTOKOJ] N9 4

!r:ec, 03.06 ,2016 rro.qr4Ha, B 09.00 rtaca, B ,,KOIl-EypIac,, EOO,[, e rca6zHera Ha\/-h--.--^--vilpaBr4Ter.q Ha ,,Kol-l-Eypnac" EooL Ha a.qpec: rp. Eypr,ac , 6yn.,,creeaHCrav6onon" Ns 73, Kov1yrcrlfl. B c.bcraB:TJnanna . n-^r-,,-

^-^-..^*^lrlrerue,4d'.r'eJt; Aapt4Ha uro.cHoBa - r,JI .Me.E, cecrpa npyI ,,KOII-EypIac"EoO.E;9neHone:1. [eaHa llerpoea - npaBocnoco6eH rop]zcr no r{r.14, an.5 or 3oll;2. MzHtto Koen - cr.eKcnepr, flupexl:vtn "3llc.UT3c-/ o6uzsa Byplac, no un.r4,aJr.5 0T 3UiI;? n,--,,^ ^--^-^,--J. Andla AB.qxr4eBa - HaqarHzr orleJr, P3IA Eyprac, no un.14, a.n.5 or 3oll;,4. IApvrHa Togopoea - Marlrcrrp-oapvralleBT, 6onHm.rHa anreKa Ha ,,KOII - Eyp;ac,,EOOLB ]43n'brHeHr4e Ha 3afioBe.q Ne 103 or 04.05 .2016 Ha Vnpaenren.a Ha .'KOU_Byp|ac" EOO.U, ce ct6pa .qa npo.ubJlxl,t cBo.qra pa6ora flo pa3r,Jrex.EaHe,.TTAHoR:ua rn -[acl4paHe Ha nocrbflI4JJI4Te oeeprz 3a yr{acr]4e e o6ulecreeHanopbr{Ka - orKpI4Ta nporle.Eypa/ c npe.UMer: ",[octaexa Ha JreKapc['BeHm npo.qyKrr4rlo npI4JToxeHa cneql4Qurcat1wa". llporle.qypara e orKpr4Ta c Peuesrae Ne

09/I4.03.2016 r., perlr4crpvrHaHa e AoII ro,q Ne 00232-2016-0003, ny6rrrcyeaHoo6.qereFrze e POll Ne 779 378/I4.03.2016 r,. u e oB Ha EC Ne 2016/S 055-091550 /18.03.2076 r.

flna -a^ltpe'4ceAaTeJI.qT Ha KO\rMCI4fr,Ta |lpoBep]4 C.bCTaBa Ha npr4C.bCTBatII4Te IA CJIe.q KaTO

yCTaHOBtI/ rIe npI4CbCTBaT BCTITIKI;4 rlJIeHOBe Ha KOMI4CVIHTa/ OI'KpI4 SaCe.UaHI4eTO.Ha 3aceEaHl4ero Ha KorrMcufr.\a He npl4cbcrBar npe.qcraBvrreJrra Ha yqacrHr4ui4['e,Ha KOT4TO 6eme I4SnpaTeHo yBe.qoMJIeHI4e 3a ,4aTaTa, r{aca w M.scToTo He_nnoRc){{Tr^rJo u: qpg$yg.

I " Kot'prcwzna nPoBexga ny6nrvnuz xpe6ldt, cnagsanZxvt c,nrepiarr,t:r peFnErMegtr:'1 Rqnvrz nna rEr . D Dy^y rryv,4ddpI4TeJIHO lIO.4rrOTBeHI4 JIUCTU Ca WBIIILCaHTA: HOMep Ha JIII , BaKoI{To IIe ce rerJII4 Npe6uilt z HaI4MeHoBaHr4ero Ha yqacrHuKa, npeIJIoxr4JI e.uHaKBaUeHa c IpyI yrlacrH]4K. 3a Bc.aKa HoMeHKJrarypa JIII ca no.qrorBeHr4 rro .UBaTaKylBa JIrLCra - |Io eIr4H 3a BCeKr4 OT yr{acrHr4l_lt1Te, KOI4TO IIe yqacTBaT BNpe6zx. flo.4lorseHl4 ca vI EBa npagHr4 6enw nnux.a, B Kor4To.ua 6sEat nocraB.sHzJTNC\IITC;2. 3a ecercl,t JIeKapcrBeH npo.qyKT ce crrbBar [pe.qBapureJrHo no.qrlorBeH:zTe JrrycrryHA ,qBAMATA YI{ACTHTIKA I/I Ce nocTaB,'IT B oT.qeJIH]4Te [JIyIKoBe;3. 9nen ga KortvrcrAfl.Ta I4grerJIfl, e4vrH or .uBara [J]yrKa, orBap.c ro IA oroBecr.qBaHal,IMeHoBaHt4eTo Ha JIll rA Ha yrlacrHr4Ka, xolZro ce o6.qn.sBa 3a c[eqeJr]4Jl xpe6m.q;4 Rqnwrz frrA-m) rrnaurmDDr,^y rLvLvLe rlIeH'bT Ha KOMI4CI4,]Ta 3anI4CBa - nbpBo M.qCTO u Ce IO.qtII4CBa/cJle.q Koero .qpyrrl4 .qBaMa r{JIeHoBe Ha KOMtlCVrfl.Ta Cbtqo noEnt4cBaT Jrucra;5 Omp:nq no r^ DmahrrnmvLDqy^ ve v! BTOpvl.qT rIJIIIK, KafO B'bpxy JIUCTa B HeIO Ce 3anI4CBa - BTOpOM.qcTo u ce roJlarraT no.urTvrcure Ha cbtq]4Te qJIeHOBe Ha KoMtlcrLfl,rai6 Tlnnlran\/nrm.rrrv+vAy' ce noBTap.c 3a BCeKr4 JIll or.qerHo;7 . 3a Npe6mx 3a JIII 4.8. 3anlrcvrre Bbpxy r43rerrJreHr4Te lrucra ca cborBerHo -BTOpO r4 TpeTo M.qcTo.Pesynrarztre or trgltteFJrelt'tz xpe6ti't, ca KarcEro cJreABa:

N}PBOMflCTO

BTOPOMfiCTO

TPETOMffCTO

4 2u01 tstso1/NO1 BBO2 Lidocaine &mg/mL10ml 10@ COOAPMA MEAEKC

4 c01 BD01 Amiodarone'U

50 mghL3ml 120 MEEEKC oboH14KC4 4 c01cA04 Dopamine Hydrochloride concenkate lor soU on { mghl -5 ml 1m COOAPMA ObOHHKC5 3 AO3ADO2 Drotaverine 40mg 2 600 MEAEKC oboH14Kc4 o c03cA01 Furosemide l0 mghl- 2ml 12@ X TbPF.NTTA MEEEKC

II. Ha ocnoBaHr4e ugBlBpureHoEo, KoMrdcvrrrrac'b.qbpxaqa oKoHr{aEeJrHotro Knacr4)aHe no BCVI:JKV|cneqr@unaq,r4.sra Ha B.sg.noxr4TeJT.rr, a rzMeHHo:

c'rcraB.q cJIe.uBarqara ra6.nuqa,JIII o[ o6oco6enlare no3rAuvrrA or

onNe

N9

B

onATC NN

NbPBO MffCTO BTOPO MFCTO TPETO MffCTO 14

cnEABAUII42 3

1. Anrrrpou6orlqHu neKapcrBa 5 800

1 BOlAB05 Enoxaparin sodium [lledsr @ lU/0,4n1 5@ MEIEKC oboHhKc COOAPMA1 BOlAB06 Nadroparin 3em tu 16m MEAEKC COOAPMA oboHhKc1 J B0tA806 Nadroparin 57@ tU 200 MEAEKC COOAPMA oboHt4Kc

1 BO1 AB1 2 Bemiparin sodium 25@tU 35@ OAPKOII X X1 5 BO1AB1 2 Bemiparin sodium 35@tU 100 oboHt4Kc COOAPMA X

2. 14n$ysuonxx pa3rBopt4 1+600

2 1 BO5BA1 O

Ol. Olivarum 15%,Amino acidsol,6 3%,+E; Glucosesol 18 75 %

20@ml @ MEEEKC X X

2 2 BO5BBO,l

Electrolytes(Magnesium chloridehexahydrate0,39;Sodium chloride5,269; Potassiumchloride 0,379;Sodiumacetate trihydrate3,689;SodiumGluconate 5.02qll)

1o@ml 30@ X

) 3 B05BBOl

Eteclrotytes(Magnesium chloridehexahydrate0,39;Sodium chloride5,269; Potassiumchloride 0,379;Sodiumacetate trihydrate3,689;SodiumGluconate 5 02oll\

500n1 40@ X X X

2 4 B05BC01 Mannitol 1@g/l{@ ml 20m MEAEKC X X

5 v06Dc01 Glucose/Sodiumchloride

50 g/9 g{1o@ml 500 MEAEKC X X

6 B05CB01 Sodium chloride (LDPE)0,9% - 1@

ml30@ OAPKOfl oboH14KC X

t 7 B05CB01 Sodium chloride 0,9% -2$ml 20@ MEAEKC X X

3. Axru6arrepHanHh neKapcrBa 2100

3 1 J01AA02 Doxycycline t00mg fl0 oboH14Kc COOAPMA OAPKON

3 2 J01 CR02Amoxicillin/ Clavulanicacid

abl, frh 875 m9r'15mg

500 X X X

3 3 JO1DDO,1 Cefotaxime r9 € MEEEKC TTPTOBCI(AflnrA X

J 4 JO1 FA1 O Azithromycin 500m9 s OAPKOII X X

J 5 JO1 FAI O Azithromycin labl frlm.Somg 70 MEAEKC OAPKOfl X

3 6 JO1 GBO3 Gentamicin injetion { mghF 2d 350 OAPKOII MEAEKC oboH14KCCOOAPMA

3 7 JOl G806 Am kac n 500 mg/2 ml -2nl 250 COOAPMA oboHflKc OAPKOII

J 8 JO1 MAO2 Ciprofloxacin abl frlm -500ms 320 OAPKOJI X X

o I JOl MA1 2 Levofloxacin 500m9 & T-bPTOBCKAII14FA

OAPKOII X

3 JOlXAO2 Teicoplanin 40 mg s COOAPMA oboHhKc X

o JOlXBOl Colistimethate sodium MU s OAPKOJI MEAEKC X

4. Ilerapcrea 3a neqeHhe Ha crpAeqHo-cBAoBHsa6onneaHus 5 280

4 1 c0tM05 Digoxin sl InJInt 05 n!r'2m| 150 COOAPMA X X

4 t c01 BB01/NO1 BBO2 Lidocaine 20mg/mL10d 0@ COOAPMA MEAEKC X

4 J c01 BD01 Amiodarone S mg/ml3ml 120 MEAEr{C oboHt4Kc COOAPMA

4 c01 cA04DopamineHydrochloride

4 mdml- s1@ COOAPMA oboHLlKC X

,

5 c01cM4 EpinephrineInlecllon

lmg/ml - lml 1m COOAPMA X X4 o c01 DA02 Glyceryl trinitrate I mg/ml- 50m1 60 MEAEKC X X4 7 c02Ac01 Clonidine 0 15ms €@ COOAPMA X X

4 I c03cA01 Furosemide 10 mg/ml -2nl 12@ COOAPMA TbPIOBGI(A

fl1/TA MEAEKC

c03cA04 Torasemide omg s0 oboHt4Kc X X4 c03cA04 Torasemide 20 mg/4 ml 300 oboHt4Kc COOAPMA X4 c03cA04 Torasemide I 0 ms/2 ml 10@ oboHLlKC COOAPMA X

5, fl poueoeu3nanHrenHn H o6e36onrBaurhneKapcTBa I 500

5 1 MOlAB05 Diclofenac sodium T5mgBml 750 MEIEKC OAPKOII X

5 MOlABO5C)rnhenadrine nilrata

75mgFomg25hl 500 OAPKOII oboH14KC MEAEKC

5 AO3AD02 Drotaverine iniecUon 40mg 25m MEEEKC oboHt4Kc OAPKOII5 NO2BBO2 Metamizole sodium l0@m92ml 4s@ MEEEKC oboHt4Kc OAPKOII5 5 N02BEOl Palacetamol 1ommg/l@ml X X X

6. flporlreoeu3nanurenHH neKapcrBa 2760

MOlAEOS Ketoprofen 1ohg 2@ MEEEr(C TbP|OBCI(AnnfA

COOAPMAoboHLlKC

o M0tAE1 7 Dexketoprofen 50mg 25m COOAPMA oboHt4Kc Xo MO1 AHO4 Parecoxib 4mg s oboH14KC COOAPMA X

7. Arruxelroparh qH H r,t a HTuaHeM H q H h neKapcrBa 180

7 1 B02BA0l Phytomenadione 10mg 60 oboHhKc COOAPMA X7 2 B03AC02 Saccharated lron Oxid lohs 20 oboHhKc COOAPMA X

7 J B03AC06 lron (lll) - hydroxidedeltran comDlex

s0 mg/ml- 200 MEAEKC X X

8. Epyrn neKapcrBeHn npoAyfitl usaun flpunoxeuue2 xa flllC 1t 750 OAPKOII X X

C rrapqnrrlAuAmnv vlrD Dyusnu ru KJIaClfpaHe KO\IVICIAHTa npZKIIOT{Ba CBO.qTa pa6oTa U npe.qaBa HaBT =noxrare.l.q rrporoKoJr]zre or 3ace.qaHrr.rrra cu n noryr_reHr4Te o0eprt4 oryr{acTHr4r_lr4[e - 3a B3eMaHe Ha perxeHr4 e.

Kox,wtcug.zTJna nao na ma n .-+r vAvvAs r e,r .

UneHoee:

/ A . UTO.TTHOBa/

/4.IeTpoBa/

/M.Koez/

/E.Ael.xrzLesa/

/ vt. r'o4opoBa/

L.

2.

4.

gJ

Ltl-i-t l=cE'Y L^Jl='l f.rtHFP=rFiI !.F>6gJ;.^r.Y"7c-=r-i >\--r --F li

R'l-\^

3